CN115322913B - Recombinant saccharomyces cerevisiae for producing rose essential oil, and construction method and application thereof - Google Patents
Recombinant saccharomyces cerevisiae for producing rose essential oil, and construction method and application thereof Download PDFInfo
- Publication number
- CN115322913B CN115322913B CN202110508671.9A CN202110508671A CN115322913B CN 115322913 B CN115322913 B CN 115322913B CN 202110508671 A CN202110508671 A CN 202110508671A CN 115322913 B CN115322913 B CN 115322913B
- Authority
- CN
- China
- Prior art keywords
- gene
- introducing
- saccharomyces cerevisiae
- sequence
- cerevisiae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 95
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title claims abstract description 95
- 238000010276 construction Methods 0.000 title claims abstract description 36
- 241000220317 Rosa Species 0.000 title abstract description 33
- 239000000341 volatile oil Substances 0.000 title abstract description 15
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims abstract description 88
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 51
- 230000014509 gene expression Effects 0.000 claims abstract description 50
- 102220563529 Tapasin-related protein_F96W_mutation Human genes 0.000 claims abstract description 31
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims abstract description 22
- 239000005792 Geraniol Substances 0.000 claims abstract description 21
- 229940113087 geraniol Drugs 0.000 claims abstract description 21
- 101150084072 ERG20 gene Proteins 0.000 claims abstract description 20
- 101001111317 Glycine max Neryl diphosphate diphosphatase, chloroplastic Proteins 0.000 claims abstract description 15
- 101150084750 1 gene Proteins 0.000 claims abstract description 11
- 108010026318 Geranyltranstransferase Proteins 0.000 claims abstract description 7
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 7
- 101000894711 Origanum vulgare Bicyclo-germacrene synthase Proteins 0.000 claims abstract description 3
- 101000720152 Zea mays Acyclic sesquiterpene synthase Proteins 0.000 claims abstract description 3
- GVVPGTZRZFNKDS-YFHOEESVSA-N neryl diphosphate Chemical compound CC(C)=CCC\C(C)=C/COP(O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-YFHOEESVSA-N 0.000 claims abstract description 3
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 31
- 238000000855 fermentation Methods 0.000 claims description 29
- 230000004151 fermentation Effects 0.000 claims description 29
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 claims description 23
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 claims description 17
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 claims description 17
- 235000000484 citronellol Nutrition 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 238000012986 modification Methods 0.000 claims description 13
- 230000004048 modification Effects 0.000 claims description 13
- 150000003505 terpenes Chemical class 0.000 claims description 10
- 235000007586 terpenes Nutrition 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 101000888433 Ocimum basilicum Geraniol synthase, chloroplastic Proteins 0.000 claims description 7
- 101100028327 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OYE2 gene Proteins 0.000 claims description 7
- 101150071391 OYE2 gene Proteins 0.000 claims description 6
- 101150045041 ERG8 gene Proteins 0.000 claims description 4
- 101150089429 HMGR gene Proteins 0.000 claims description 4
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 claims description 3
- 101150014913 ERG13 gene Proteins 0.000 claims description 3
- 101150107463 ERG7 gene Proteins 0.000 claims description 3
- 108010006229 Acetyl-CoA C-acetyltransferase Proteins 0.000 claims description 2
- 108090000489 Carboxy-Lyases Proteins 0.000 claims description 2
- 101150051269 ERG10 gene Proteins 0.000 claims description 2
- 101150071502 ERG12 gene Proteins 0.000 claims description 2
- 101150023788 ERG19 gene Proteins 0.000 claims description 2
- 101000582994 Homo sapiens Myelin regulatory factor Proteins 0.000 claims description 2
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 claims description 2
- 108010065958 Isopentenyl-diphosphate Delta-isomerase Proteins 0.000 claims description 2
- 108700040132 Mevalonate kinases Proteins 0.000 claims description 2
- 102100030372 Myelin regulatory factor Human genes 0.000 claims description 2
- 239000013613 expression plasmid Substances 0.000 claims description 2
- 101150081406 idi1 gene Proteins 0.000 claims description 2
- 108091000116 phosphomevalonate kinase Proteins 0.000 claims description 2
- 238000009420 retrofitting Methods 0.000 claims 2
- 101150091750 HMG1 gene Proteins 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 abstract description 5
- 102000013404 Geranyltranstransferase Human genes 0.000 abstract description 2
- 230000010354 integration Effects 0.000 abstract description 2
- 239000012634 fragment Substances 0.000 description 50
- 239000002609 medium Substances 0.000 description 42
- 239000013612 plasmid Substances 0.000 description 40
- 210000004027 cell Anatomy 0.000 description 24
- 108020004414 DNA Proteins 0.000 description 20
- 230000003321 amplification Effects 0.000 description 18
- 238000003199 nucleic acid amplification method Methods 0.000 description 18
- 239000007788 liquid Substances 0.000 description 17
- 238000010079 rubber tapping Methods 0.000 description 16
- 239000007787 solid Substances 0.000 description 16
- 239000013598 vector Substances 0.000 description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 239000008103 glucose Substances 0.000 description 14
- 239000001963 growth medium Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 10
- 108020005004 Guide RNA Proteins 0.000 description 9
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 9
- 230000003213 activating effect Effects 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 7
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 6
- 101150001810 TEAD1 gene Proteins 0.000 description 6
- 101150074253 TEF1 gene Proteins 0.000 description 6
- 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 6
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 6
- 239000012452 mother liquor Substances 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 210000005253 yeast cell Anatomy 0.000 description 6
- 101000918303 Bos taurus Exostosin-2 Proteins 0.000 description 5
- 108091033409 CRISPR Proteins 0.000 description 5
- 101000801742 Homo sapiens Triosephosphate isomerase Proteins 0.000 description 5
- 102100033598 Triosephosphate isomerase Human genes 0.000 description 5
- 238000000137 annealing Methods 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 5
- 230000036425 denaturation Effects 0.000 description 5
- 238000012257 pre-denaturation Methods 0.000 description 5
- 102100024630 Asc-type amino acid transporter 1 Human genes 0.000 description 4
- 101150081875 Slc7a10 gene Proteins 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 3
- 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- 102100028652 Gamma-enolase Human genes 0.000 description 3
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 3
- 101000780443 Homo sapiens Alcohol dehydrogenase 1A Proteins 0.000 description 3
- 101001058231 Homo sapiens Gamma-enolase Proteins 0.000 description 3
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 3
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 3
- 101100376502 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YJL064W gene Proteins 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000013599 cloning vector Substances 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 229930003658 monoterpene Natural products 0.000 description 3
- 150000002773 monoterpene derivatives Chemical class 0.000 description 3
- 235000002577 monoterpenes Nutrition 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- CJUKAWUWBZCTDQ-SRVKXCTJSA-N Asp-Leu-Lys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O CJUKAWUWBZCTDQ-SRVKXCTJSA-N 0.000 description 2
- 101100434663 Bacillus subtilis (strain 168) fbaA gene Proteins 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 101100351264 Candida albicans (strain SC5314 / ATCC MYA-2876) PDC11 gene Proteins 0.000 description 2
- 241001137307 Cyprinodon variegatus Species 0.000 description 2
- 101150095274 FBA1 gene Proteins 0.000 description 2
- 101000642268 Homo sapiens Speckle-type POZ protein Proteins 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 101150050255 PDC1 gene Proteins 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 102100036422 Speckle-type POZ protein Human genes 0.000 description 2
- LHEZGZQRLDBSRR-WDCWCFNPSA-N Thr-Glu-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LHEZGZQRLDBSRR-WDCWCFNPSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229960002713 calcium chloride Drugs 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 2
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 2
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012269 metabolic engineering Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000004451 qualitative analysis Methods 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 101150003389 tdh2 gene Proteins 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229910021654 trace metal Inorganic materials 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- SSSROGPPPVTHLX-FXQIFTODSA-N Ala-Arg-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O SSSROGPPPVTHLX-FXQIFTODSA-N 0.000 description 1
- IKKVASZHTMKJIR-ZKWXMUAHSA-N Ala-Asp-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IKKVASZHTMKJIR-ZKWXMUAHSA-N 0.000 description 1
- DAEFQZCYZKRTLR-ZLUOBGJFSA-N Ala-Cys-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O DAEFQZCYZKRTLR-ZLUOBGJFSA-N 0.000 description 1
- QJABSQFUHKHTNP-SYWGBEHUSA-N Ala-Ile-Trp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O QJABSQFUHKHTNP-SYWGBEHUSA-N 0.000 description 1
- QQACQIHVWCVBBR-GVARAGBVSA-N Ala-Ile-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QQACQIHVWCVBBR-GVARAGBVSA-N 0.000 description 1
- XHNLCGXYBXNRIS-BJDJZHNGSA-N Ala-Lys-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XHNLCGXYBXNRIS-BJDJZHNGSA-N 0.000 description 1
- RNHKOQHGYMTHFR-UBHSHLNASA-N Ala-Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 RNHKOQHGYMTHFR-UBHSHLNASA-N 0.000 description 1
- PGNNQOJOEGFAOR-KWQFWETISA-N Ala-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 PGNNQOJOEGFAOR-KWQFWETISA-N 0.000 description 1
- MUGAESARFRGOTQ-IGNZVWTISA-N Ala-Tyr-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N MUGAESARFRGOTQ-IGNZVWTISA-N 0.000 description 1
- 102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 description 1
- 101710193111 All-trans-retinol dehydrogenase [NAD(+)] ADH4 Proteins 0.000 description 1
- RVDVDRUZWZIBJQ-CIUDSAMLSA-N Arg-Asn-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RVDVDRUZWZIBJQ-CIUDSAMLSA-N 0.000 description 1
- YNSGXDWWPCGGQS-YUMQZZPRSA-N Arg-Gly-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O YNSGXDWWPCGGQS-YUMQZZPRSA-N 0.000 description 1
- OQCWXQJLCDPRHV-UWVGGRQHSA-N Arg-Gly-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O OQCWXQJLCDPRHV-UWVGGRQHSA-N 0.000 description 1
- HAVKMRGWNXMCDR-STQMWFEESA-N Arg-Gly-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HAVKMRGWNXMCDR-STQMWFEESA-N 0.000 description 1
- 101150058440 Asc-1 gene Proteins 0.000 description 1
- RCFGLXMZDYNRSC-CIUDSAMLSA-N Asn-Lys-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O RCFGLXMZDYNRSC-CIUDSAMLSA-N 0.000 description 1
- AYOAHKWVQLNPDM-HJGDQZAQSA-N Asn-Lys-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AYOAHKWVQLNPDM-HJGDQZAQSA-N 0.000 description 1
- RTFXPCYMDYBZNQ-SRVKXCTJSA-N Asn-Tyr-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O RTFXPCYMDYBZNQ-SRVKXCTJSA-N 0.000 description 1
- WEDGJJRCJNHYSF-SRVKXCTJSA-N Asp-Cys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)N WEDGJJRCJNHYSF-SRVKXCTJSA-N 0.000 description 1
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 1
- DGKCOYGQLNWNCJ-ACZMJKKPSA-N Asp-Glu-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O DGKCOYGQLNWNCJ-ACZMJKKPSA-N 0.000 description 1
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 1
- WDMNFNXKGSLIOB-GUBZILKMSA-N Asp-Met-Met Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)O)N WDMNFNXKGSLIOB-GUBZILKMSA-N 0.000 description 1
- JDDYEZGPYBBPBN-JRQIVUDYSA-N Asp-Thr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JDDYEZGPYBBPBN-JRQIVUDYSA-N 0.000 description 1
- NWAHPBGBDIFUFD-KKUMJFAQSA-N Asp-Tyr-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O NWAHPBGBDIFUFD-KKUMJFAQSA-N 0.000 description 1
- 101150085381 CDC19 gene Proteins 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 241000221955 Chaetomium Species 0.000 description 1
- KGIHMGPYGXBYJJ-SRVKXCTJSA-N Cys-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS KGIHMGPYGXBYJJ-SRVKXCTJSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101100110003 Danio rerio pycard gene Proteins 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102100039555 Galectin-7 Human genes 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- JFOKLAPFYCTNHW-SRVKXCTJSA-N Gln-Arg-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)N)N JFOKLAPFYCTNHW-SRVKXCTJSA-N 0.000 description 1
- QYTKAVBFRUGYAU-ACZMJKKPSA-N Gln-Asp-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QYTKAVBFRUGYAU-ACZMJKKPSA-N 0.000 description 1
- JJKKWYQVHRUSDG-GUBZILKMSA-N Glu-Ala-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O JJKKWYQVHRUSDG-GUBZILKMSA-N 0.000 description 1
- ZJICFHQSPWFBKP-AVGNSLFASA-N Glu-Asn-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZJICFHQSPWFBKP-AVGNSLFASA-N 0.000 description 1
- HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 1
- UMIRPYLZFKOEOH-YVNDNENWSA-N Glu-Gln-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UMIRPYLZFKOEOH-YVNDNENWSA-N 0.000 description 1
- PVBBEKPHARMPHX-DCAQKATOSA-N Glu-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O PVBBEKPHARMPHX-DCAQKATOSA-N 0.000 description 1
- BUAKRRKDHSSIKK-IHRRRGAJSA-N Glu-Glu-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 BUAKRRKDHSSIKK-IHRRRGAJSA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- LXXANCRPFBSSKS-IUCAKERBSA-N Gly-Gln-Leu Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LXXANCRPFBSSKS-IUCAKERBSA-N 0.000 description 1
- STVHDEHTKFXBJQ-LAEOZQHASA-N Gly-Glu-Ile Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O STVHDEHTKFXBJQ-LAEOZQHASA-N 0.000 description 1
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 1
- PTIIBFKSLCYQBO-NHCYSSNCSA-N Gly-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN PTIIBFKSLCYQBO-NHCYSSNCSA-N 0.000 description 1
- MYXNLWDWWOTERK-BHNWBGBOSA-N Gly-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN)O MYXNLWDWWOTERK-BHNWBGBOSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- PZAJPILZRFPYJJ-SRVKXCTJSA-N His-Ser-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O PZAJPILZRFPYJJ-SRVKXCTJSA-N 0.000 description 1
- IAYPZSHNZQHQNO-KKUMJFAQSA-N His-Ser-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CN=CN2)N IAYPZSHNZQHQNO-KKUMJFAQSA-N 0.000 description 1
- 101000608772 Homo sapiens Galectin-7 Proteins 0.000 description 1
- BGZIJZJBXRVBGJ-SXTJYALSSA-N Ile-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N BGZIJZJBXRVBGJ-SXTJYALSSA-N 0.000 description 1
- GECLQMBTZCPAFY-PEFMBERDSA-N Ile-Gln-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GECLQMBTZCPAFY-PEFMBERDSA-N 0.000 description 1
- GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 1
- OTSVBELRDMSPKY-PCBIJLKTSA-N Ile-Phe-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N OTSVBELRDMSPKY-PCBIJLKTSA-N 0.000 description 1
- CNMOKANDJMLAIF-CIQUZCHMSA-N Ile-Thr-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O CNMOKANDJMLAIF-CIQUZCHMSA-N 0.000 description 1
- PZWBBXHHUSIGKH-OSUNSFLBSA-N Ile-Thr-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PZWBBXHHUSIGKH-OSUNSFLBSA-N 0.000 description 1
- APQYGMBHIVXFML-OSUNSFLBSA-N Ile-Val-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N APQYGMBHIVXFML-OSUNSFLBSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- DQPQTXMIRBUWKO-DCAQKATOSA-N Leu-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(C)C)N DQPQTXMIRBUWKO-DCAQKATOSA-N 0.000 description 1
- WUFYAPWIHCUMLL-CIUDSAMLSA-N Leu-Asn-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O WUFYAPWIHCUMLL-CIUDSAMLSA-N 0.000 description 1
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 1
- FIYMBBHGYNQFOP-IUCAKERBSA-N Leu-Gly-Gln Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N FIYMBBHGYNQFOP-IUCAKERBSA-N 0.000 description 1
- KGCLIYGPQXUNLO-IUCAKERBSA-N Leu-Gly-Glu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O KGCLIYGPQXUNLO-IUCAKERBSA-N 0.000 description 1
- OMHLATXVNQSALM-FQUUOJAGSA-N Leu-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(C)C)N OMHLATXVNQSALM-FQUUOJAGSA-N 0.000 description 1
- FKQPWMZLIIATBA-AJNGGQMLSA-N Leu-Lys-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FKQPWMZLIIATBA-AJNGGQMLSA-N 0.000 description 1
- KPYAOIVPJKPIOU-KKUMJFAQSA-N Leu-Lys-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O KPYAOIVPJKPIOU-KKUMJFAQSA-N 0.000 description 1
- JDBQSGMJBMPNFT-AVGNSLFASA-N Leu-Pro-Val Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O JDBQSGMJBMPNFT-AVGNSLFASA-N 0.000 description 1
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- NQCJGQHHYZNUDK-DCAQKATOSA-N Lys-Arg-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCN=C(N)N NQCJGQHHYZNUDK-DCAQKATOSA-N 0.000 description 1
- BYEBKXRNDLTGFW-CIUDSAMLSA-N Lys-Cys-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O BYEBKXRNDLTGFW-CIUDSAMLSA-N 0.000 description 1
- NJNRBRKHOWSGMN-SRVKXCTJSA-N Lys-Leu-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O NJNRBRKHOWSGMN-SRVKXCTJSA-N 0.000 description 1
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 1
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 1
- LUAJJLPHUXPQLH-KKUMJFAQSA-N Lys-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N LUAJJLPHUXPQLH-KKUMJFAQSA-N 0.000 description 1
- LKDXINHHSWFFJC-SRVKXCTJSA-N Lys-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N LKDXINHHSWFFJC-SRVKXCTJSA-N 0.000 description 1
- FPQMQEOVSKMVMA-ACRUOGEOSA-N Lys-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CCCCN)N)O FPQMQEOVSKMVMA-ACRUOGEOSA-N 0.000 description 1
- HMZPYMSEAALNAE-ULQDDVLXSA-N Lys-Val-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMZPYMSEAALNAE-ULQDDVLXSA-N 0.000 description 1
- OSOLWRWQADPDIQ-DCAQKATOSA-N Met-Asp-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OSOLWRWQADPDIQ-DCAQKATOSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- 101100234604 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ace-8 gene Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 101150040663 PGI1 gene Proteins 0.000 description 1
- 101150093629 PYK1 gene Proteins 0.000 description 1
- ISYSEOWLRQKQEQ-JYJNAYRXSA-N Phe-His-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O ISYSEOWLRQKQEQ-JYJNAYRXSA-N 0.000 description 1
- KBVJZCVLQWCJQN-KKUMJFAQSA-N Phe-Leu-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KBVJZCVLQWCJQN-KKUMJFAQSA-N 0.000 description 1
- XZQYIJALMGEUJD-OEAJRASXSA-N Phe-Lys-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XZQYIJALMGEUJD-OEAJRASXSA-N 0.000 description 1
- 101150096292 Ppme1 gene Proteins 0.000 description 1
- CKXMGSJPDQXBPG-JYJNAYRXSA-N Pro-Cys-Trp Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O CKXMGSJPDQXBPG-JYJNAYRXSA-N 0.000 description 1
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 1
- HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 1
- XQPHBAKJJJZOBX-SRVKXCTJSA-N Pro-Lys-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O XQPHBAKJJJZOBX-SRVKXCTJSA-N 0.000 description 1
- RMODQFBNDDENCP-IHRRRGAJSA-N Pro-Lys-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O RMODQFBNDDENCP-IHRRRGAJSA-N 0.000 description 1
- 108010079005 RDV peptide Proteins 0.000 description 1
- 101100247325 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RAS2 gene Proteins 0.000 description 1
- SRTCFKGBYBZRHA-ACZMJKKPSA-N Ser-Ala-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SRTCFKGBYBZRHA-ACZMJKKPSA-N 0.000 description 1
- HVKMTOIAYDOJPL-NRPADANISA-N Ser-Gln-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O HVKMTOIAYDOJPL-NRPADANISA-N 0.000 description 1
- SFTZTYBXIXLRGQ-JBDRJPRFSA-N Ser-Ile-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SFTZTYBXIXLRGQ-JBDRJPRFSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- ZKBKUWQVDWWSRI-BZSNNMDCSA-N Ser-Phe-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKBKUWQVDWWSRI-BZSNNMDCSA-N 0.000 description 1
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 description 1
- HSWXBJCBYSWBPT-GUBZILKMSA-N Ser-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O HSWXBJCBYSWBPT-GUBZILKMSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- GKMYGVQDGVYCPC-IUKAMOBKSA-N Thr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)N GKMYGVQDGVYCPC-IUKAMOBKSA-N 0.000 description 1
- RRRRCRYTLZVCEN-HJGDQZAQSA-N Thr-Leu-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O RRRRCRYTLZVCEN-HJGDQZAQSA-N 0.000 description 1
- PZSDPRBZINDEJV-HTUGSXCWSA-N Thr-Phe-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PZSDPRBZINDEJV-HTUGSXCWSA-N 0.000 description 1
- RQKMZXSRILVOQZ-GMVOTWDCSA-N Trp-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N RQKMZXSRILVOQZ-GMVOTWDCSA-N 0.000 description 1
- SWSUXOKZKQRADK-FDARSICLSA-N Trp-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N SWSUXOKZKQRADK-FDARSICLSA-N 0.000 description 1
- WVRUKYLYMFGKAN-IHRRRGAJSA-N Tyr-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 WVRUKYLYMFGKAN-IHRRRGAJSA-N 0.000 description 1
- GFJXBLSZOFWHAW-JYJNAYRXSA-N Tyr-His-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GFJXBLSZOFWHAW-JYJNAYRXSA-N 0.000 description 1
- PMHLLBKTDHQMCY-ULQDDVLXSA-N Tyr-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMHLLBKTDHQMCY-ULQDDVLXSA-N 0.000 description 1
- FDKDGFGTHGJKNV-FHWLQOOXSA-N Tyr-Phe-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FDKDGFGTHGJKNV-FHWLQOOXSA-N 0.000 description 1
- RGJZPXFZIUUQDN-BPNCWPANSA-N Tyr-Val-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O RGJZPXFZIUUQDN-BPNCWPANSA-N 0.000 description 1
- FZSPNKUFROZBSG-ZKWXMUAHSA-N Val-Ala-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O FZSPNKUFROZBSG-ZKWXMUAHSA-N 0.000 description 1
- VLDMQVZZWDOKQF-AUTRQRHGSA-N Val-Glu-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VLDMQVZZWDOKQF-AUTRQRHGSA-N 0.000 description 1
- SZTTYWIUCGSURQ-AUTRQRHGSA-N Val-Glu-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SZTTYWIUCGSURQ-AUTRQRHGSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 101150063416 add gene Proteins 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-CTWWJBIBSA-L calcium;3-[[(2s)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate Chemical compound [Ca+2].OCC(C)(C)[C@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-CTWWJBIBSA-L 0.000 description 1
- 101150038500 cas9 gene Proteins 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- GFHNAMRJFCEERV-UHFFFAOYSA-L cobalt chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Co+2] GFHNAMRJFCEERV-UHFFFAOYSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 1
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000012526 feed medium Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 101150079592 gene 20 gene Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 238000011090 industrial biotechnology method and process Methods 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010091871 leucylmethionine Proteins 0.000 description 1
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 1
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010075702 lysyl-valyl-aspartyl-leucine Proteins 0.000 description 1
- CNFDGXZLMLFIJV-UHFFFAOYSA-L manganese(II) chloride tetrahydrate Chemical compound O.O.O.O.[Cl-].[Cl-].[Mn+2] CNFDGXZLMLFIJV-UHFFFAOYSA-L 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 1
- 229940073769 methyl oleate Drugs 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 1
- 108700042769 prolyl-leucyl-glycine Proteins 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- RWVGQQGBQSJDQV-UHFFFAOYSA-M sodium;3-[[4-[(e)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-n-ethyl-3-methylanilino]methyl]benzenesulfonate Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=C1 RWVGQQGBQSJDQV-UHFFFAOYSA-M 0.000 description 1
- XETSAYZRDCRPJY-UHFFFAOYSA-M sodium;4-aminobenzoate Chemical compound [Na+].NC1=CC=C(C([O-])=O)C=C1 XETSAYZRDCRPJY-UHFFFAOYSA-M 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01088—Hydroxymethylglutaryl-CoA reductase (1.1.1.88)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/07—Diphosphoric monoester hydrolases (3.1.7)
- C12Y301/07006—Farnesyl diphosphatase (3.1.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/03—Carbon-oxygen lyases (4.2) acting on phosphates (4.2.3)
- C12Y402/03051—Beta-phellandrene synthase (neryl-diphosphate-cyclizing) (4.2.3.51)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses recombinant saccharomyces cerevisiae, a construction method and application thereof. The construction method comprises the following steps of modifying the original saccharomyces cerevisiae to obtain recombinant saccharomyces cerevisiae: a1, introducing a geraniol synthase gene ObGES gene; a2, introduction of the double point mutant Gene ERG20 at positions 96 and 127 of the farnesyl pyrophosphate synthetase Gene F96W/N127W A gene; a3, introducing A3-hydroxy-3-methylglutaryl-CoA reductase gene tHMG1 gene; a4, introducing a geraniol reductase gene OYE 2; a5, introducing a nerol synthase GmNES gene; a6, introducing a neryl diphosphate synthase SINPS 1 gene. The construction method successfully realizes the construction of the rose essential oil microbial cell factory in saccharomyces cerevisiae through heterologous expression, module integration and branch interception regulation and control of farnesyl pyrophosphate synthetase.
Description
Technical Field
The invention relates to the technical field of biology, in particular to recombinant saccharomyces cerevisiae for producing rose essential oil, and a construction method and application thereof.
Background
Rose essential oils are the most expensive essential oils in the world, called "after essential oils" "" liquid gold ". The rose essential oil is yellow brown, has unique fragrance, is widely applied to daily chemicals, medicines, foods and other industries, and has great practical value. About 3000 kg-5000 kg of rose petals are needed to extract 1kg of rose essential oil according to the traditional extraction method, the yield is very low, and the traditional extraction and separation are easy to cause environmental pollution and other problems. At present, as the rose essential oil yield is low and the demand is large, large market gaps exist in China, and how to improve the production technology becomes a problem which needs to be solved urgently.
Since the last 30 th century, microorganisms have been used in large quantities for industrial fermentation production, and fermentation products have been spread over many fields such as chemical industry, foods, and medicines. Metabolic engineering is a science linking cell metabolism to increase metabolite production or to confer new product production capabilities to microbial cells, and has found wide application in the development of cell factories. Saccharomyces cerevisiae (Saccharomyces cerevisiae), which is widely used in the synthetic biotechnology industry because it is generally considered to be in a safe (GRAS) state suitable for large-scale operation, has now been developed as one of the important platform microorganisms for metabolic engineering.
Disclosure of Invention
The invention provides a construction method of recombinant saccharomyces cerevisiae, which comprises the following steps: the method comprises the following steps of modifying the original saccharomyces cerevisiae to obtain recombinant saccharomyces cerevisiae:
a1, introducing a geraniol synthase gene ObGES gene; a2, introduction of the double point mutant Gene ERG20 at positions 96 and 127 of the farnesyl pyrophosphate synthetase Gene F96W/N127W A gene; a3, introducing A3-hydroxy-3-methylglutaryl-CoA reductase gene tHMG1 gene; a4, introducing a geraniol reductase gene OYE 2; a5, introducing a nerol synthase GmNES gene; a6, introducing a neryl diphosphate synthase SINPS 1 gene.
Optionally, the construction method comprises the following steps: the following modifications are also carried out on the Saccharomyces cerevisiae:
b1, replacing a promoter of an ERG20 gene of a driving farnesyl pyrophosphate synthetase gene with a promoter of an ERG7 gene named pERG 7; b2, introducing a mevalonate kinase gene ERG 12; b3, introducing an isopentenyl pyrophosphate isomerase gene IDI 1; b4, introducing an MVAPP decarboxylase gene ERG 19; b5, introducing HMG-CoA reductase gene HMGR gene; b6, introducing a 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase gene ERG13 gene; b7, introducing an MVAP kinase gene ERG8 gene; b8, introducing an acetyl-CoA acetyltransferase gene ERG 10.
The construction method of the recombinant saccharomyces cerevisiae can also comprise the step of expressing the introduced genes.
The Saccharomyces cerevisiae may be wild-type Saccharomyces cerevisiae, such as Saccharomyces cerevisiae CEN.PK2-1D, or may be modified Saccharomyces cerevisiae.
Optionally, according to the above construction method, the sequence of the obj gene encoded by the obj gene is genbank accession number: AMK97466.1 sequence 35-569; and/or, the ERG20 F96W/N127W Gene encoded ERG20 F96W/N127W Protein sequences such as SEQ ID No. 10; and/or, the sequence of the tHMG1 protein coded by the tHMG1 gene is genbank login number: AJS96703.1 sequence is shown at positions 530-1054; and/or, the sequence of the OYE2 protein encoded by the OYE2 gene is genbank login number: the sequence NP 012049.1 is shown; and/or, the sequence of the GmNES protein encoded by the GmNES gene is genbank login number: AEE92791.1 sequence; and/or, the SINPS 1 protein coded by the SINPS 1 gene has the sequence of genbank login number: the QNM36897.1 sequence is shown.
Optionally, according to the above construction method, the sequence of the obj gene is shown in SEQ ID No.8 from position 431 to position 2035; and/or, the ERG20 F96W/N127W The sequence of the gene is shown in 2048 th to 3106 th positions in SEQ ID NO. 8; and/or the sequence of the tHMG1 gene is shown in 757 th to 2340 th positions in SEQ ID NO. 2; and/or the sequence of the OYE2 gene is shown in the 801 st position to the 2003 st position in SEQ ID NO. 7; and/or the sequence of the GmNES gene is shown in the 801 st position to 2405 th position in SEQ ID NO. 3; and/or the sequence of the SINPS 1 gene is shown in the 431 th to 1213 rd positions of SEQ ID NO. 4.
The B1 may replace the above-mentioned promoter by CRISPR/CAS9 system, and specifically, CAS9 gene, gRNA gene and DNA fragment containing pERG7 promoter (for example, pERG20-pERG7 fragment used in examples) may be introduced into the Saccharomyces cerevisiae and CAS9 gene and gRNA gene are expressed. The gRNA fragment encoded by the gRNA gene targets the promoter driving the ERG20 gene (pERG 20 promoter). The target sequence may be TTTCTACTTGCCTGTCGCAT, for example.
Alternatively, according to the above construction method, the A1 and A2 are obtained by introducing an ObGES gene and ERG20 into the Saccharomyces cerevisiae F96W/N127W Gene expression cassettes (e.g., P TEF1 -ObGES-ERG20 F96W/N127W -T CYC1 An expression cassette, the sequence of which is shown as SEQ ID No. 8); and/or, the A3 is obtained by introducing into the Saccharomyces cerevisiae a tHMG1 gene expression cassette (e.g., P PGK1 -tHMG1-T ADH1 An expression cassette, the sequence of which is shown as SEQ ID No. 2); and/or, the A4 is obtained by introducing an OYE2 gene expression cassette (e.g., P TDH3 -OYE2-T TPI1 An expression cassette, the sequence of which is shown as SEQ ID No. 7); and/or, the A5 is obtained by introducing into the Saccharomyces cerevisiae of interest a GmNES gene expression cassette (e.g., P TDn3 -GmNES-T TPI1 An expression cassette, the sequence of which is shown as SEQ ID No. 3); and/or, the A6 is obtained by introducing a SINPS 1 gene expression cassette (e.g., P TEF1 -SINDPS1-T CYC1 An expression cassette, the sequence of which is shown as SEQ ID No. 4); and/or, the B2 is obtained by introducing an ERG12 gene expression cassette (e.g., P PDC1 -ERG12-T ADH2 Expression cassette) implementation; and/or, the B3 is obtained by introducing an IDI1 gene expression cassette (e.g.P ENO2 -IDI1-T PDC1 Expression cassette) implementation; and/or, the B4 is obtained by introducing an ERG19 gene expression cassette (e.g., P PYK1 -ERG19-T PGI1 Realizing an expression cassette; and/or, the B5 is obtained by introducing an HMGR gene expression cassette (e.g., P TEF2 -HMGR-T ENO2 Expression cassette) implementation; and/or, the B6 is obtained by introducing an ERG13 gene expression cassette (e.g., P FBA1 -ERG13-T TDH2 Expression cassette) implementation; and/or, the B7 is obtained by introducing an ERG8 gene expression cassette (e.g., P TDH3 -ERG8-T TPI1 Expression cassette) implementation; and/or, the B8 is obtained by introducing an ERG10 gene expression cassette (e.g., P TEF1 -ERG10-T CYC1 Expression cassette).
Alternatively, according to the above construction method, in the recombinant Saccharomyces cerevisiae, the ObGES gene and ERG20 gene F96W/N127W The gene is expressed by introducing an expression plasmid in the saccharomyces cerevisiae; tHMG1 gene, obGES gene and ERG20 F96W /N127W The gene is integrated into the GAL7 locus of the Saccharomyces cerevisiae; the tHMG1 gene, the GmNES gene and the SINTS 1 gene are integrated into the NDT80 locus of the Saccharomyces cerevisiae; the pERG7 replaces positions 1-248 of the promoter driving the ERG20 gene. The genes B2-B8 described above can be integrated into the YJL064W locus of the Saccharomyces cerevisiae.
Recombinant Saccharomyces cerevisiae constructed by the above method is also within the scope of the present invention.
The invention also provides a method for producing terpenes, which comprises the steps of culturing the recombinant saccharomyces cerevisiae to obtain a fermentation product; terpenes are obtained from the fermentation product.
Any of the following applications is also within the scope of the present invention,
x1, application of the method in preparing and producing terpene products; x2, use of the above method for producing terpenes; x3, application of the recombinant saccharomyces cerevisiae in preparing and producing terpene products; x4, application of the recombinant saccharomyces cerevisiae in terpene production.
In the above, the terpene may be at least one selected from geraniol, citronellol, nerol.
In the above, the terpene product may be a recombinant bacterium expressing a terpene.
The main components of the natural rose essential oil are monoterpene compounds citronellol, geraniol and nerol, and in the invention, the construction of a rose essential oil microbial cell factory is successfully realized in saccharomyces cerevisiae through heterologous expression, module integration and branch closure regulation and control of farnesyl pyrophosphate synthetase (ERG 20).
Drawings
FIG. 1 shows the GC-MS analysis results of the Rose year B strain product, wherein A is the peak pattern of the strains NEROL-pERG7, rose year B and the standard of NEROL (Nerol), geraniol (Geraniol) and Citronellol (Citronellol), B (1) is the MS pattern of the database Geraniol, B (2) is the MS pattern of the Geraniol in the Rose year B strain product, C (1) is the MS pattern of the database Citronellol, C (2) is the MS pattern of the Citronellol in the Rose year B strain product, D (1) is the MS pattern of the database NEROL, D (2) is the MS pattern of the NEROL in the Rose year B strain product.
Detailed Description
The following detailed description of the invention is provided in connection with the accompanying drawings that are presented to illustrate the invention and not to limit the scope thereof. The examples provided below are intended as guidelines for further modifications by one of ordinary skill in the art and are not to be construed as limiting the invention in any way.
The experimental methods in the following examples, unless otherwise specified, are conventional methods, and are carried out according to techniques or conditions described in the literature in the field or according to the product specifications. Materials, reagents and the like used in the examples described below are commercially available unless otherwise specified.
Data were processed using SPSS11.5 statistical software and experimental results were expressed as mean.+ -. Standard deviation using One-way ANOVA.
The following examples used the following media and components in particular:
SD solid selection medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His (available from panno technology limited, beijing), 2% glucose, 0.01% Leu (leucine), 0.005% His (histidine), 0.01% Ura (uracil), 0.01% Trp (tryptophan), and 2% agar powder;
SD liquid selection medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His,2% glucose, 0.01% Leu, 0.005% His, 0.01% Ura, 0.01% Trp;
SD-Trp solid selection Medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His,2% glucose, 0.01% Leu, 0.005% His, 0.01% Ura, 2% agar powder;
SD-Trp liquid selection Medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His,2% glucose, 0.01% Leu, 0.005% His, 0.01% Ura:
SD-Trp-Ura solid selection Medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His,2% glucose, 0.01% Leu, 0.005% His,2% agar powder;
SD-Trp-5FOA solid selection Medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His,2% glucose, 0.01% Leu, 0.005% His, 0.01% Ura, 0.05%5-foa, 2% agar powder;
SD-Trp-His solid selection Medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His,2% glucose, 0.01% Leu, 0.01% Ura, 2% agar powder;
SD-Trp-His liquid selection Medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His,2% glucose, 0.01% Leu, 0.01% Ura;
SD-Trp-Leu solid selection Medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His (available from pantuno technology limited, beijing), 2% glucose, 0.005% His (histidine), 0.01% Ura (uracil) and 2% agar powder;
SD-Trp-Leu liquid selection Medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His,2% glucose, 0.005% His, 0.01% Ura;
SD-Trp-Ura-His-Leu solid screening culture medium: 0.8% yeast selection medium SD-Ura-Trp-Leu-His,2% glucose, 2% agar powder.
The information on the gene fragments and protein sequences in the examples described below is given in the following table.
Gene fragment and protein sequence-related information
Protein related information
Example 1
1. Construction of promoter element and acquisition of functional Gene
1. PCR amplification
Saccharomyces cerevisiae CEN.PK2-1D (hereinafter referred to as NK2, purchased from European Saccharomyces cerevisiae collection (EUROSCARF)) genomic DNA was extracted using the Kangji yeast genome extraction kit (cat# CW 0569), and the genome was extracted according to the manufacturer's instructions. The genome DNA of saccharomyces cerevisiae NK2 is used as a template, the primer collocation in the table 1 is adopted respectively, the promoter fragments pERG7 (the pERG7 promoter is the-1 to-774 positions on the upstream of the ERG7 gene) are obtained through respective amplification, and then the promoter fragments pERG20-pERG7 are obtained through amplification by using the primer containing the homologous arm of the pERG20 promoter region.
The amplification system is as follows: TAKARA (Takara Shuzo)Hs DNA polymerase 5 XPS Buffer 10. Mu.l, dNTPMmix 4. Mu.l, primers 1.5. Mu.l each, DNA template 0.5. Mu.l,/10. Mu.l>HS polymerase (2.5U/. Mu.l) 0.5. Mu.l supplemented with ddH 2 O to a total volume of 50. Mu.l.
The amplification conditions were as follows: pre-denaturation at 98 ℃ for 3min (1 cycle); denaturation at 98℃for 10 seconds, annealing at 58℃for 15 seconds, extension at 72℃for 3 minutes (30 cycles); extension at 72℃for 10min (1 cycle). And (5) recovering and storing the product through rubber tapping.
TABLE 1 primer sequences
2. Total synthesis of related genes
The SINSPS 1 gene and the GmNES gene were completely synthesized by the client gold biosciences, and inserted between SexA1 and Asc1 cloning sites of pUC57 vector (supplied by gold biosciences, inc.), to obtain cloning plasmids pUC 57-SINSPS 1 and pUC57-GmNES.
2. Construction of recombinant plasmids
Construction of pEASY-TRP1-URA3 plasmid
The plasmids pRS314 and pGAL7-URA3 are respectively used as templates, and the primers in the primer table 2 are used for amplification to obtain 871bp TRP1 fragment and 1128bp URA3 fragment; then, using TRP1 and URA3 fragments as templates, and using the primers in the primer table 2, a 1999bp TRP1-URA3 fragment was obtained by amplification. (pRS 314) is described in documents Ma Xiaolin, li Weixian, wang Dong, etc. Hederasapogenin biosynthesis analysis and construction of yeast cell factories [ J ]. J.Chinese traditional medicine, 2018, 043 (009): 1844-1850. PGAL7-URA3 is described in documents Lin Tingting, wang Dong, put on waves, etc. A yeast cell factory is created to ferment and produce lupeol [ J ]. J.Chinese traditional Chinese traditional medicine, 2016, 41 (06): 1008-1015. A yeast cell factory is produced.
The amplification system is as follows: TAKARA (Takara Shuzo)HS DNA polymerase 5 XPS Buffer 10. Mu.l, dNTPMmix 4. Mu.l, primers 1.5. Mu.l each, DNA template 0.5. Mu.l,/o>HS polymerase (2.5U/. Mu.l) 0.5. Mu.l supplemented with ddH 2 O to a total volume of 50. Mu.l.
The amplification conditions were as follows: pre-denaturation at 98 ℃ for 3min (1 cycle); denaturation at 98℃for 10 seconds, annealing at 58℃for 15 seconds, extension at 72℃for 3 minutes (30 cycles); extension at 72℃for 10min (1 cycle). And (5) recovering and storing the product through rubber tapping.
Cloning the amplified product TRP1-URA3 into a Trans1-T1 competent cell transformed by a pEASY-Blunt Simple cloning vector, extracting plasmid sequencing and verifying to obtain a plasmid pEASY-TRP-URA.
TABLE 2 primer collocation
2.pRS425-ObGES-ERG20 F96W/N127W 、pRS425-LEU-TRP-URA-ObGES-ERG20 F96W/N127W Construction of plasmids
With pM3-GES and pM4-ERG20 F96W/N127W The plasmid was used as template (pM 3-GES, pM4-ERG 20) F96W-N127W The description is in the article: tao W, siwei L, bolin Z, et al engineering Saccharomyces cerevisiae for the production of the valuable monoterpene ester geranyl acetate [ J]Microbial Cell Factories,2018, 17 (1): 85. in (C), the primers in Table 3 were used to amplify the resulting ObGES-ERG20 F96W/N127W A gene fragment.
After purification of the fragments obtained above, the plasmids pRS425-LEU2-TEF1-SynPn3-29 (stored in the laboratory, recorded in the laboratory) were digested with the restriction enzymes SexA1 and Asc1, respectivelyArticles Wang, d., wang, j., shi, y., li, r.,&zhang, x. (2020) Elucidation of the complete biosynthetic pathway of the main triterpene glycosylation products of panax notoginseng using a synthetic biology plan, metabic Engineering, 61), and fragment oges-ERG 20 F96W/N127W Then the rubber tapping is recovered.
Recovering target fragments by tapping: pRS425-LEU2-TEF1-// -CYC1 (7576 bp,120 ng) vector (pRS 425-LEU2-P TEF1 -Pn3-32-T CYC1 Rubber cutting recovery product) and ObGES-ERG20 F96W/N127W (fragment ObGES-ERG 20) F96W/N127W The product was recovered from the tapping) (2763 bp,105 ng) fragment. Respectively connecting the target fragment and the corresponding vector, wherein the connection system is as follows: mu.l 2X Quick Ligation Buffer (NEB Co., ltd.), 0.5. Mu.l Quick T4 DNA Ligase (NEB Co., 400,00 cohesive end units/ml), and ddH were supplemented 2 O to 10 mul, reacting for 10min at 25 ℃ to obtain a connection product, transferring into a Transl T1 competent cell, and carrying out sequencing verification to obtain a recombinant vector pRS425-LEU-TEF1-ObGES-ERG20 F96W /N127W (i.e., pRS425-ObGES-ERG20 F96W/N127W )。
The TRP-URA fragment was amplified using the primers shown in Table 3, and plasmids pRS425-LEU-TEF1-ObGES-ERG20 were digested with restriction enzymes Xma I and NOT I, respectively F96W/N127W And the fragment TRP-URA. P425-LEU-// -TEF1-ObGES-ERG20 F96W/N127W CYC1 (50 ng) vector (pRS 425-LEU-TEFi-ObGES-ERG20 F96W/N127W Rubber cut recovery product) and TRP-URA (130 ng) (fragment TRP-URA rubber cut recovery product). Respectively connecting the target fragment and the corresponding vector, wherein the connection system is as follows: mu.l of 2X Quick Ligation Buffer (NEB Co., ltd.), 0.5. Mu.l of Quick T4 DNA Ligase (NEB Co., 400,000cohesive end units/ml), and ddH were supplemented 2 O to 10 μl, reacting at 25deg.C for 10min to obtain ligation product, transferring into Transl T1 competent cells, and performing sequencing verification to obtain pRS425-LEU-TRP-URA-ObGES-ERG20 F96W /N127W A plasmid.
Construction of YJL064W-gRNA, pERG20gRNA plasmid
The pLPPgRNA is used as a template, and the primers in the table 3 are respectively matched, so that gRNA fragments YJL064W-gRNA and pERG20-gRNA are respectively obtained through amplification. The amplified gRNA fragment PCR product is treated by Dpnl enzyme for more than three hours, then 5-10 mu l is transferred into Trans 1T 1 competent cells and is subjected to sequencing verification, and YJL064W-gRNA plasmid and pERG20gRNA plasmid are obtained, and the related information of the plasmids is shown in Table 5. ( pLPPgRNA is described in: wang, d., wang, j, shi, y, li, r, & Zhang, x (2020) & Elucidation of the complete biosynthetic pathway of the main triterpene glycosylation products of panax notoginseng using a synthetic biology platform.metabic Engineering,61 )
TABLE 3 primer sequences
4. Construction of pRS 425-SINPS 1, pM4-OYE2, pM4-GmNES recombinant plasmid
(1) PCR amplification
The functional gene fragment of geraniol reductase OYE2 is amplified by taking genomic DNA of saccharomyces cerevisiae NK2 as a template and adopting primers in a table 3.
(2) Construction of recombinant plasmid by enzyme digestion and ligation
After purification of the fragments obtained above, plasmids pRS425-LEU2-TEF1-SynPn3-29, pUC57-GmNES, pUC 57-SINSPS 1 and plasmid pM4-tHMG1 (stored in the laboratory, described in Tao W, siwei L, bolin Z, et al engineering Saccharomyces cerevisiae for the production of the valuable monoterpene ester geranyl acetate [ J ]. Microbial Cell Factories,2018, 17 (1): 85) and fragment OYE2 were digested with restriction enzymes, respectively, and then the resulting pM4 and p425 vectors with the cohesive ends of the sites of SexA1, ASC1 and fragments of OYE2, SINSS 1, gmNES were recovered by tapping.
Recovering target fragments by tapping: pEASY-Blunt-TDH3-// -TPI1 (5749 bp,100 ng) vector (plasmid pM4-tHMG1 tapping recovery product) and GmNES (plasmid pUC57-GmNES tapping recovery product) (1605 bp,20 ng), OYE2 (fragment OYE2 tapping recovery product) (1203 bp,30 ng) fragment, p425-LEU2-TEF 1-/-CYC 1 (120 ng) vector (plasmid pRS425-LEU2-TEF1-SynPn3-29 rubber cut recovery product) and SINPS 1 (783 bp,20 ng) (fragment SINPS 1 rubber cut recovery product). Respectively connecting the target fragment and the corresponding vector, wherein the connection system is as follows: mu.l of 2X Quick Ligation Buffer (NEB Co., ltd.), 0.5. Mu.l of Quick T4 DNA Ligase (NEB Co., 400,000cohesive end units/ml), and ddH were supplemented 2 O to 10 μl, reacting at 25deg.C for 10min to obtain a ligation product, transferring into Trans 1T 1 competent cells, and performing sequencing verification to obtain recombinant vector.
The recombinant vector has been sequenced to insert the expression cassette of the gene between cloning sites of the cloning vector and was designated pRS 425-SINTS 1, pM4-OYE2, pM4-GmNES.
5. plasmid construction of pM7-HMGR
The genomic DNA of Saccharomyces cerevisiae NK2 was used as a template, the primers Pac1-TEF2-F and SexA1-TEF2-R were used for amplification to obtain the promoter pTEF2 (562 bp), and the primers Asc1-ENO2-F and Pme1-ENO2-R were used for amplification to obtain the terminator tENO2 (400 bp). The amplification system is as follows: primeSTAR GXL Buffer (Mg2+plus). Times.10. Mu.l, dNTPMmix. Times.4. Mu.l, primers Pac1-TEF2-F and SexA1-TEF2-R (Asc 1-ENO2-F and Pme1-ENO 2-R) were each 1.5. Mu.l, genomic DNA template was 1.5. Mu.l, primeSTAR GXL DNA Polymerase (1.25U/. Mu.l) 1. Mu.l, and ddH2O was added to a total volume of 50. Mu.l.
Pac1-TEF2-F:5’-GCTTAATTAAATGGGGCCGTATACTTACATATAGTAGA-3’
SexA1-TEF2-R:5’-GCACCAGGTGTTTAGTTAATTATAGTTCGTTGACCGTATATTCTAAAAAC-3’
Asc1-ENO2-F:5’-GCGGCGCGCCAGTGCTTTTAACTAAGAATTATTAGTCTTTTCTGCT-3’
Pme1-ENO2-R:5’-GCGTTTAAACAGGTATCATCTCCATCTCCCATATGC-3’
The plasmid pUC57-synHMGR is digested with restriction enzymes SexA I and Asc I respectively, and the target fragment is recovered by tapping to obtain a fragment SexA I-synHMGR-Asc I; cutting the section pTEF2 by using restriction endonucleases SexA I and pac I respectively, and recovering a target fragment by tapping to obtain SexA I-pTEF2-pac I; cutting the segment tENO2 by restriction enzymes Asc1 and Pme1 respectively, recovering the target segment by tapping to obtain Asc1-tENO2-Pme1, and adding 50ng of each of the three segments into a connecting system: 2ul 10XT4 ligationBuffer (NEB Co.) 1ul T4 ligase(NEB Co., 400,000cohesive end units/ml), distilled water was supplemented to 20ul, and the reaction was carried out at room temperature for 2 hours to give a ligation product, 1ul of the ligation product was added, and the PCR system: primeSTAR GXL Buffer (Mg2+plus) x 10. Mu.l, dNTPMmix 4. Mu.l, primers Pac1-TEF2-F and Pme1-ENO2-R each 1.5. Mu.l, ligation product 1. Mu.l, primeSTAR GXL DNA Polymerase (1.25U/. Mu.l) 1. Mu.l, and ddH2O were added to a total volume of 50. Mu.l to give an expression cassette P TEF2 -HMGR-T ENO2 . The expression cassette was cloned into pEASY-Blunt Simple cloning vector (purchased from Beijing full gold Biotechnology Co., ltd.) to obtain recombinant vector pM7-HMGR.
The information on the recombinant vector prepared above is shown in Table 4.
TABLE 4 recombinant vector information
3. Construction of recombinant bacteria
Construction of Chaetomium HP001-pERG7-ERG20
The amplification system is as follows: TAKARA (Takara Shuzo)HS DNA polymerase 5 XPS Buffer 10. Mu.l, dNTPMmix 4. Mu.l, primers 1.5. Mu.l each, DNA template 0.5. Mu.l,/o>HS polymerase (2.5U/. Mu.l) 0.5. Mu.l supplemented with ddH 2 O to a total volume of 50. Mu.l.
The amplification conditions were: pre-denaturation at 98 ℃ for 3min (1 cycle); denaturation at 98℃for 10 seconds, annealing at 58℃for 15 seconds, extension at 72℃for 3 minutes (30 cycles); extension at 72℃for 10min (1 cycle). And (5) recovering and storing the product through rubber tapping.
TABLE 5 primer information
Activating yeast bottom in SD liquid mediumDisc cells NK2, competent cells were prepared by lithium acetate method. Mu.l of p414-TEF1p-Cas9-CYC1t plasmid (stored in laboratory, purchased from addgene.) was added and transformants were streaked on SD-Trp solid selection medium after incubation for 48 hours at 30 ℃. Activating the strain obtained in the above manner in SD-Trp liquid selection medium, and preparing competent cells by using a lithium acetate method. 2. Mu.l of YJL064W-gRNA plasmid was added to the competence, and N1, N2, N3, N4, N5, N6 (P) amplified as described above was added FBA1 -ERG13-T TDH2 ) And 8 modular segments of N7 and N8 (total 8. Mu.l) were added to the yeast competent cells in a molar ratio of 1:1:1:1:1:1:1. Transformants were streaked after culturing in SD-Trp-Ura solid selection medium at 30℃for 48 hours in an incubator, and PCR was performed to verify that the correct strain was cultured in SD-Trp-5FOA solid selection medium for 24 hours to eliminate the gRNA plasmid, designated HP001.
The construction principle of HP001 is that recombinant plasmid p414-PTEF1-Cas9-TCYC1 capable of expressing Cas9 protein is transferred into strain NK2 in advance, then recombinant plasmid (YJL 064W-gRNA plasmid) capable of expressing gRNA is transformed into strain together with recombinant fragment (N1-N8), YJL064W-gRNA plasmid recognizes and binds specific PAM region of YJL064W site, at the same time, cas9 protein is activated and guided to exert cleavage function, double-stranded DNA of YJL064W site is broken, at the moment, recombinant fragment N1-N8 containing homologous region is integrated into strain DNA by homologous recombination repair.
Yeast chassis cells HP001 were activated in SD-Trp medium and competent cells were prepared by lithium acetate method. The pERG20gRNA plasmid obtained above, together with the fragment pERG20-pERG7, was added to yeast competent cells at a molar ratio of 1:1. Transformants were incubated in SD-Trp-Ura solid screening medium at 30℃for 48 hours in an incubator. Extracting yeast genome, using the extracted strain genome as a template, adopting the following primers to amplify fragments by PCR, and verifying by sequencing, wherein the correct strain is named HP001-pERG7-ERG20.
ERG20-OUT-F:CGGCTCTTACGCCATAACCTTTATG
ERG20-R:CTTCAGGTGCAGTGATTAAGTCCATC
Construction of recombinant Strain
1. Construction of high-yield nerol strain
(1) Construction of Gene Module
The PCR templates described in Table 6 (pNDT 80-HIS3, described in articles Zhang Lili, ma Xiaolin, wang Dong, yu Peng, huang Luqi,&zhang Xueli et al (2017) Yeast cell factory creation of high-yield nerolidol journal of Chinese traditional medicine, 42 (015), 2962-2968, p delta-tHMG 1 is described in literature: journal of chinese traditional medicine, lin Tingting, wang Dong, wear waves, zhang Xueli, huang Luqi, 2016, 41 (6): 1008-1015) and corresponding primers to obtain functional modules respectively: m1 (comprising the NDT80-HIS3-up fragment), M2 (comprising P) PGK1 -tHMG1-T ADH1 Expression cassette), M3 (comprising P TDH3 -GmNES-T TPI1 Expression cassette), M4 (comprising P TEF1 -SINDPS1-T CYC1 Expression cassette), M5 (comprising NDT80-HIS3-down fragment).
The amplification system is as follows: TAKARA (Takara Shuzo)HS DNA polymerase 5 XPS Buffer 10. Mu.l, dNTPMmix 4. Mu.l, primers 1.5. Mu.l each, RNA template 0.5. Mu.l,/o>HS polymerase (2.5U/. Mu.l) 0.5. Mu.l supplemented with ddH 2 O to a total volume of 50. Mu.l.
The amplification conditions were: pre-denaturation at 98 ℃ for 3min (1 cycle); denaturation at 98℃for 10 seconds, annealing at 58℃for 15 seconds, extension at 72℃for 3 minutes (30 cycles); extension at 72℃for 10min (1 cycle). And (5) recovering and storing the product through rubber tapping.
TABLE 6 primer sequences
(2) Construction of recombinant strains
The resulting chassis strain HP001-pERG7-ERG20 was subjected to elimination of the gRNA plasmid with SD-5FOA-Trp plates. Activating yeast chassis cells HP001-pERG7-ERG20 in SD-TRP culture medium, and preparing competent cells by a lithium acetate method. M1, M2, M3, M4, M5 were each added to the yeast competent cells in a molar ratio of 1:1:1:1:1 (total 5. Mu.l). Transformants were streaked after culturing in SD-Trp-His solid screening medium in an incubator at 30℃for 48 hours. Activating the strain in SD-Trp-His liquid culture medium, extracting yeast genome with the method, taking the extracted strain genome as a template, verifying functional genes according to primer collocation in Table 7, verifying that the correct strain is named NEROL-pERG7, shaking seed liquid, and performing shake flask fermentation.
TABLE 7 primer sequences
2. Construction of Rose essential Yeast Strain
(1) Construction of Gene Module
PCR amplification was performed using the PCR templates and the corresponding primers described in Table 8, respectively, to obtain functional modules: m6 (containing GAL7-URA3-up fragment), M7 (containing P) PGK1 -tHMG1-T ADH1 Expression cassette), M8 (comprising P TDH3 -OYE2-T TPI1 Expression cassette), M9 (comprising P TEF1 -ObGES-ERG20 F96W/N127W -T CYC1 Expression cassette), M10 (comprising GAL7-URA3-down fragment).
The amplification system is as follows: TAKARA (Takara Shuzo)HS DNA polymerase 5 XPS Buffer 10 μl, dNTPMmix 4 μl, primers 1.5 μl each, RNA template 0.5 μl,/10 μl>HS polymerase (2.5U/. Mu.l) 0.5. Mu.l supplemented with ddH 2 O to a total volume of 50. Mu.l.
The amplification conditions were: pre-denaturation at 98 ℃ for 3min (1 cycle); denaturation at 98℃for 10 seconds, annealing at 58℃for 15 seconds, extension at 72℃for 3 minutes (30 cycles); extension at 72℃for 10min (1 cycle). And (5) recovering and storing the product through rubber tapping.
TABLE 8 primer sequences
(2) Construction of recombinant strains
Activating the engineering yeast cell NEROL-pERG7 obtained in the above way in SD-Trp-His culture medium, and preparing competent cells by a lithium acetate method. M6, M7, M8, M9, M10 were collocated and added to yeast competent cells in a molar ratio of 1:1:1:1:1 (total 5. Mu.L). Transformants were streaked after culturing in SD-Trp-Ura-His solid screening medium in an incubator at 30℃for 48 hours. Activating the strain in SD-Trp-Ura-His liquid culture medium, extracting yeast genome by the method, taking the extracted strain genome as a template, verifying functional genes according to the primer collocation PCR in table 9, verifying that the correct strain is named as Rose year A, shaking seed liquid, and performing shake flask fermentation.
TABLE 9 primer sequences
3. Optimization of rose essential oil yeast strains
After eliminating the plasmid containing the TRP1 selection marker in the Rose yeast A strain by reverse screening in YPD medium, the engineering yeast cell Rose yeast A obtained above was activated in SD-His-Ura medium, and competent cells were obtained by lithium acetate method. Mu.l pRS425-LEU-TRP-URA-ObGES-ERG20 F96W/N127 The plasmid was added to yeast competent cells. Transformants were streaked after 48 hours of incubation in SD-Trp-Ura-His-Leu solid screening medium at 30 ℃. Activating strain in SD-Trp-Ura-His-Leu liquid culture medium, extracting strain fermentThe master plasmid (yeast plasmid was extracted according to manufacturer's instructions using the Tiangen yeast plasmid extraction kit (product number: DP 112-02)) and the yeast plasmid extracted was used as a template to verify the functional plasmid according to the primer set in Table 10, and the correct strain was named Rose yeast B and the seed solution was shaken for shake flask fermentation.
TABLE 10 primer sequences
The information on the recombinant bacteria prepared above is shown in Table 11.
TABLE 11 engineering strain information
4. Shake flask fermentation and detection
1. Engineering bacteria culture and product extraction
According to Table 12, the yeast engineering strain prepared as described above was activated in the corresponding solid selection medium, seed solution (30 ℃,250rpm,16 h) was prepared in the corresponding liquid selection medium, inoculated in a 100ml Erlenmeyer flask containing 15ml of the corresponding liquid selection medium at an inoculum size of 1%, shake-cultured at 30 ℃,250rpm for 1 day, then 1.5ml of methyl oleate was added, and shake-cultured was continued for 5 days. Finally, the liquid in the triangular flask was transferred to a 50ml centrifuge tube, centrifuged at 5000rpm for 5min, and the organic phase was collected for use.
TABLE 12 Medium used for culturing strains
Strain name | Solid selection medium | Liquid selection medium |
NEROL-pERG7 | SD-Trp-His | SD-Trp-His |
Rose yeast A | SD-Trp-Ura-His | SD-Trp-Ura-His |
Rose yeast B | SD-Trp-Ura-His-Leu | SD-Trp-Ura-His-Leu |
2. Qualitative and quantitative analysis
GC-MS detection
The converted material was diluted 10-fold with n-hexane, passed through an organic nylon membrane (0.22 μm) and detected by GC-MS. Detection instrument: agilent gas chromatograph-mass spectrometer Agilent 7890A/5975C.
NEROL-pERG7 strain fermentation product GC-MS assay conditions: the temperature of the sample inlet is 250 ℃, the sample inlet volume is 1 mu L, no flow division is performed, and the solvent is delayed for 3min; chromatographic column: HP-5ms (30 m.0.25 mM); chromatographic conditions: preserving heat at 45 ℃ for 1min at 10 ℃/min to 300 ℃ for 5min; MS conditions: full Scan:50-750amu. Qualitative and quantitative determination was performed using a standard of nerol, which was purchased from Zhejiang river Biotechnology Co., ltd.
Conditions for GC-MS measurement of the fermentation products of the Rose eye A and Rose eye B strains: the temperature of the sample inlet is 250 ℃, the sample inlet volume is 1 mu L, no flow division is performed, and the solvent is delayed for 3min; chromatographic column: HP-5ms (30 m.0.25 mM); chromatographic conditions: preserving heat at 70 ℃,35min,3 ℃/min to 115 ℃,20 ℃/min to 300 ℃ for 5min; MS conditions: full Scan:50-750amu. The quality and quantity of geraniol, citronellol and nerol standard products are respectively purchased from Allatin company, shanghai Yuan Ye Biotechnology Co., ltd, zhejiang Ling Biotechnology Co., ltd, geraniol (product number: G107515), citronellol (product number: G107515) and nerol (product number: N0077).
The experiment was repeated three times, and as a result, the yield of each engineering bacterium at 6 days of fermentation was as follows:
NEROL yield of NEROL-pERG7 strain was 12.46mg/L.
The yield of nerol of Rose yeast A reaches 3.37mg/L, the yield of citronellol reaches 35.51mg/L, and the yield of geraniol reaches 22.70mg/L.
The yield of nerol of Rose yeast B reaches 12.78mg/L, the yield of citronellol reaches 77.24mg/L, the yield of geraniol reaches 33.96mg/L, and the GC-MS analysis result of the fermentation product is shown in FIG. 1.
3. Bioreactor fermentation culture
1) Culture medium configuration
Calcium chloride mother liquor: 19.2g/L calcium chloride dihydrate.
Trace metal salt mother liquor: 19.1g/L disodium ethylenediamine tetraacetate; 10.2g/L zinc sulfate heptahydrate; 0.5g/L manganese chloride tetrahydrate; 0.86g/L cobalt chloride hexahydrate; 0.78g/L copper sulfate pentahydrate; 0.56g/L sodium molybdate dihydrate; 5.12g/L of seven Shui Ya ferric sulfate.
Vitamin mother liquor: 0.05g/L biotin; 0.2g/L sodium p-aminobenzoate; 1g/L nicotinic acid; 1g/L calcium pantothenate; 1g/L pyridoxine hydrochloride; 1g/L thiamine hydrochloride; 25g/L inositol.
Seed medium and fermentation medium: 25g/L glucose, 15g/L ammonium sulfate, 6.15g/L magnesium sulfate heptahydrate, 0.72g/L zinc sulfate heptahydrate, 8g/L potassium dihydrogen phosphate, 2ml/L calcium chloride mother liquor and 10ml/L trace metal salt mother liquor; 12ml/L vitamin mother liquor, 1g/L tryptophan, and the balance of water.
Feed medium: 800g/L glucose, 5.125g/L magnesium sulfate heptahydrate, 3.5g/L potassium sulfate, 0.28g/L sodium sulfate, 9g/L potassium dihydrogen phosphate, 1g/L tryptophan and the balance being water.
2) Engineering bacterium Rose yeast B fermentation
Activating engineering bacteria Rose yeast B by the method of '1, engineering bacteria culture and product extraction'. After the amino acid screening mark is supplemented, the monoclonal on the flat plate is selected to a test tube filled with SD-Trp-Ura-His-Leu culture medium, and the culture is carried out at 30 ℃ with shaking at 250rpm for overnight; sucking 500 mu L of bacterial liquid into a 250ml triangular flask filled with 50ml of SD-Trp-Ura-His-Leu culture medium, and carrying out shaking culture at 30 ℃ for 24 hours at 250 rpm;
picking up the monoclonal on the plate to a test tube filled with sD-TRP-Ura-His-Leu medium, and culturing at 30 ℃ with shaking at 250rpm for overnight; sucking 500 mu L of bacterial liquid into a 250ml triangular flask filled with 50ml of SD-Ura-His-Leu culture medium, and carrying out shaking culture at 30 ℃ for 24 hours at 250 rpm;
respectively sucking 2ml of bacterial liquid into 3 1L triangular flasks filled with 100ml of seed culture medium, and carrying out shaking culture at 30 ℃ and 250rpm for 48 hours; finally, the seed solution was added to a 7L fermenter containing 3L of fermentation medium via a flame inoculation loop (Eppendorf company, germany, model:) Is a kind of medium.
The parameter set values in the fermentation process are respectively as follows: the temperature is 30 ℃, the pH is 5.0, the dissolved oxygen is 30%, the air flow is 3-20L/min, the stirring rotating speed is 300-1000rpm, and the dissolved oxygen, the stirring rotating speed and the ventilation are cascaded. When the dissolved oxygen value is more than 60%, feeding a feeding culture medium into the fermentation tank until the glucose concentration in the fermentation liquid is 5g/L.
3 hours before the end of fermentation, 10% (relative to the volume of the broth) of olive oil was added, and the organic phase was separated after the end of fermentation.
The method is processed according to a conversion method and a detection method of '2 and qualitative and quantitative analysis', and the engineering bacterium Rose year B is subjected to high-density fermentation for 96 hours to obtain 0.32g/L (relative to the culture solution) of nerol, 3.89g/L (relative to the culture solution) of citronellol and 0.66g/L (relative to the culture solution) of geraniol.
Recombinant bacteria meeting the purposes of the present invention, including but not limited to the specific experimental examples described in the table, can be fermented and cultured according to the fermentation method described in "3, bioreactor fermentation and culture" to obtain rose essential oil.
Specific information on the expression cassette in the above N2-N8 fragment and the pERG20-pERG7 fragment are given in the following table.
Expression cassette in N2-N8 fragment and pERG20-pERG7 fragment related information table
Expression cassette in N2-N8 fragment and pERG20-pERG7 fragment sequence table
The present invention is described in detail above. It will be apparent to those skilled in the art that the present invention can be practiced in a wide range of equivalent parameters, concentrations, and conditions without departing from the spirit and scope of the invention and without undue experimentation. While the invention has been described with respect to specific embodiments, it will be appreciated that the invention may be further modified. In general, this application is intended to cover any variations, uses, or adaptations of the invention following, in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains. The application of some of the basic features may be done in accordance with the scope of the claims that follow.
Sequence listing
<110> institute of Tianjin Industrial biotechnology, national academy of sciences
<120> recombinant Saccharomyces cerevisiae for producing rose essential oil, construction method and application thereof
<130> 210858
<160> 10
<170> SIPOSequenceListing 1.0
<210> 1
<211> 726
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
ggctcgtatg ttgtgtggaa ttgtgagcgg ataacaattt cacacaggaa acagctatga 60
ccatgattac gccaagctct gttccattga tttcttctct attgttatat cataattttc 120
atgaggtaat tcattgattt ttttgaatgc taatgagcct actttgaaaa tattctcatg 180
ttcaaaagag cgtgccggtt tcagttcgat ttgcttcata ttaacagaaa aactacttga 240
gtaaactaaa tcctcctttt ctaaacaccc ttccatacct cttgaagatg aactcggata 300
tttcagagag gaatctggac attgattttt caaagcaccc agtttgttct ggatatgttc 360
aagagtctcc acccttttat ttggcctgaa gaacggatcc tcattttcct tcgaagcttc 420
cattggtgtg gattgacgag atttgatagg cgagatggag gccccagagt tcggtgcacc 480
tagcgccact ttggatcgcc ttttcgaagg tcttgcattt aagcaacttt catttaacgg 540
ctgcgccatt gatggcattt ttctttttgt gctgttttgt gaggaattga cactcgacgg 600
tgttctcaca gttattcgct gagatgacgc atagttagaa ggtgatcttc ctctaataat 660
aagaggaggc gttttcattt cttgcaaata cacaaacatc ccttttgatc cattttttaa 720
agccag 726
<210> 2
<211> 2498
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
acgcacagat attataacat ctgcacaata ggcatttgca agaattactc gtgagtaagg 60
aaagagtgag gaactatcgc atacctgcat ttaaagatgc cgatttgggc gcgaatcctt 120
tattttggct tcaccctcat actattatca gggccagaaa aaggaagtgt ttccctcctt 180
cttgaattga tgttaccctc ataaagcacg tggcctctta tcgagaaaga aattaccgtc 240
gctcgtgatt tgtttgcaaa aagaacaaaa ctgaaaaaac ccagacacgc tcgacttcct 300
gtcttcctat tgattgcagc ttccaatttc gtcacacaac aaggtcctag cgacggctca 360
caggttttgt aacaagcaat cgaaggttct ggaatggcgg gaaagggttt agtaccacat 420
gctatgatgc ccactgtgat ctccagagca aagttcgttc gatcgtactg ttactctctc 480
tctttcaaac agaattgtcc gaatcgtgtg acaacaacag cctgttctca cacactcttt 540
tcttctaacc aagggggtgg tttagtttag tagaacctcg tgaaacttac atttacatat 600
atataaactt gcataaattg gtcaatgcaa gaaatacata tttggtcttt tctaattcgt 660
agtttttcaa gttcttagat gctttctttt tctctttttt acagatcatc aaggaagtaa 720
ttatctactt tttacaacaa atataaaaca aaaacaatgg ctgcagacca attggtgaaa 780
actgaagtca ccaagaagtc ttttactgct cctgtacaaa aggcttctac accagtttta 840
accaataaaa cagtcatttc tggatcgaaa gtcaaaagtt tatcatctgc gcaatcgagc 900
tcatcaggac cttcatcatc tagtgaggaa gatgattccc gcgatattga aagcttggat 960
aagaaaatac gtcctttaga agaattagaa gcattattaa gtagtggaaa tacaaaacaa 1020
ttgaagaaca aagaggtcgc tgccttggtt attcacggta agttaccttt gtacgctttg 1080
gagaaaaaat taggtgatac tacgagagcg gttgcggtac gtaggaaggc tctttcaatt 1140
ttggcagaag ctcctgtatt agcatctgat cgtttaccat ataaaaatta tgactacgac 1200
cgcgtatttg gcgcttgttg tgaaaatgtt ataggttaca tgcctttgcc cgttggtgtt 1260
ataggcccct tggttatcga tggtacatct tatcatatac caatggcaac tacagagggt 1320
tgtttggtag cttctgccat gcgtggctgt aaggcaatca atgctggcgg tggtgcaaca 1380
actgttttaa ctaaggatgg tatgacaaga ggcccagtag tccgtttccc aactttgaaa 1440
agatctggtg cctgtaagat atggttagac tcagaagagg gacaaaacgc aattaaaaaa 1500
gcttttaact ctacatcaag atttgcacgt ctgcaacata ttcaaacttg tctagcagga 1560
gatttactct tcatgagatt tagaacaact actggtgacg caatgggtat gaatatgatt 1620
tctaaaggtg tcgaatactc attaaagcaa atggtagaag agtatggctg ggaagatatg 1680
gaggttgtct ccgtttctgg taactactgt accgacaaaa aaccagctgc catcaactgg 1740
atcgaaggtc gtggtaagag tgtcgtcgca gaagctacta ttcctggtga tgttgtcaga 1800
aaagtgttaa aaagtgatgt ttccgcattg gttgagttga acattgctaa gaatttggtt 1860
ggatctgcaa tggctgggtc tgttggtgga tttaacgcac atgcagctaa tttagtgaca 1920
gctgttttct tggcattagg acaagatcct gcacaaaatg ttgaaagttc caactgtata 1980
acattgatga aagaagtgga cggtgatttg agaatttccg tatccatgcc atccatcgaa 2040
gtaggtacca tcggtggtgg tactgttcta gaaccacaag gtgccatgtt ggacttatta 2100
ggtgtaagag gcccgcatgc taccgctcct ggtaccaacg cacgtcaatt agcaagaata 2160
gttgcctgtg ccgtcttggc aggtgaatta tccttatgtg ctgccctagc agccggccat 2220
ttggttcaaa gtcatatgac ccacaacagg aaacctgctg aaccaacaaa acctaacaat 2280
ttggacgcca ctgatataaa tcgtttgaaa gatgggtccg tcacctgcat taaatcctaa 2340
agttataaaa aaaataagtg tatacaaatt ttaaagtgac tcttaggttt taaaacgaaa 2400
attcttattc ttgagtaact ctttcctgta ggtcaggttg ctttctcagg tatagcatga 2460
ggtcgctctt attgaccaca cctctaccgg catgccga 2498
<210> 3
<211> 2807
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
atactagcgt tgaatgttag cgtcaacaac aagaagttta atgacgcgga ggccaaggca 60
aaaagattcc ttgattacgt aagggagtta gaatcatttt gaataaaaaa cacgcttttt 120
cagttcgagt ttatcattat caatactgcc atttcaaaga atacgtaaat aattaatagt 180
agtgattttc ctaactttat ttagtcaaaa aattagcctt ttaattctgc tgtaacccgt 240
acatgcccaa aatagggggc gggttacaca gaatatataa catcgtaggt gtctgggtga 300
acagtttatt cctggcatcc actaaatata atggagcccg ctttttaagc tggcatccag 360
aaaaaaaaag aatcccagca ccaaaatatt gttttcttca ccaaccatca gttcataggt 420
ccattctctt agcgcaacta cagagaacag gggcacaaac aggcaaaaaa cgggcacaac 480
ctcaatggag tgatgcaacc tgcctggagt aaatgatgac acaaggcaat tgacccacgc 540
atgtatctat ctcattttct tacaccttct attaccttct gctctctctg atttggaaaa 600
agctgaaaaa aaaggttgaa accagttccc tgaaattatt cccctacttg actaataagt 660
atataaagac ggtaggtatt gattgtaatt ctgtaaatct atttcttaaa cttcttaaat 720
tctactttta tagttagtct tttttttagt tttaaaacac caagaactta gtttcgaata 780
aacacacata aacaaacaaa atggataata tctatattaa acaagcattg gttttgaagg 840
aagttaagca tgttttccaa aaattgatcg gtgaagatcc aatggaatct atgtacatgg 900
ttgatacaat ccaaagattg ggtatcgaac atcatttcga agaagaaatc gaagctgcat 960
tgcaaaagca acatttgatt ttctcttctc atttgtctga tttcgcaaac aaccataaat 1020
tgtgtgaagt tgctttgcct tttagattgt tgagacaaag aggtcattac gttttggcag 1080
atgttttcga taatttgaag tcaaataaga aagaattcag agaaaaacat ggtgaagatg 1140
ttaagggttt gatttcttta tacgaagcta ctcaattggg tattgaaggt gaagattcat 1200
tggatgatgc aggttactta tgtcatcaat tgttacatgc ttggttaact agacatgaag 1260
aacataacga agcaatgtac gttgctaaga cattgcaaca tccattacat tacgatttgt 1320
ctagattcag agatgatact tcaatcttgt tgaacgattt caagacaaaa agagaatggg 1380
aatgtttgga agaattagca gaaattaatt cttcaatcgt tagattcgtt aatcaaaatg 1440
aaattacaca agtttacaag tggtggaagg atttgggttt aaataacgag gttaagttcg 1500
caagatacca accattgaag tggtacatgt ggccaatggc ttgttttact gatccaagat 1560
tttcagaaca aagaatcgaa ttgacaaaac caatttcttt agtctacatc atcgatgata 1620
tttttgatgt ttacggtact ttggatcaat tgactttgtt tactgatgca attaaaagat 1680
gggaattggc ttctactgaa caattgccag atttcatgaa gatgtgtttg agagttttgt 1740
acgaaattac aaatgatttt gctgaaaaga tttgtaagaa acatggtttt aatccaattg 1800
aaactttgaa gagatcttgg gttagattgt tgaacgcatt tttagaagaa gctcattggt 1860
tgaactctgg tcatttgcca agatcagcag aatatttgaa caacggtatc gtttcaacag 1920
gtgttcatgt tgttttggtt cattctttct ttttgatgga ttactcaatt aataatgaaa 1980
ttgttgctat cgttgataac gttccacaaa tcatccattc tgttgcaaag atcttgagat 2040
tgtcagatga tttggaaggt gctaaatctg aagatcaaaa cggtttggat ggttcataca 2100
tcgattgtta catgaacgaa catcaagatg tttctgcagg tgacgctcaa agacatgttg 2160
ctcatttgat ttcatgtgaa tggaagagat taaatagaga aatcttgact caaaaccaat 2220
tgccatcttc ttttactaac ttttgtttga atgctgcaag aatggttcca ttgatgtacc 2280
attacagatc taacccaggt ttgtcaactt tgcaagaaca tgttaaattg ttgtctaata 2340
atgctgttgc aggtgctgaa agacatgttg ttcatatttt gtgtttacaa tttgttattg 2400
aataagatta atataattat ataaaaatat tatcttcttt tctttatatc tagtgttatg 2460
taaaataaat tgatgactac ggaaagcttt tttatattgt ttctttttca ttctgagcca 2520
cttaaatttc gtgaatgttc ttgtaaggga cggtagattt acaagtgata caacaaaaag 2580
caaggcgctt tttctaataa aaagaagaaa agcatttaac aattgaacac ctctatatca 2640
acgaagaata ttactttgtc tctaaatcct tgtaaaatgt gtacgatctc tatatgggtt 2700
actcataagt gtaccgaaga ctgcattgaa agtttatgtt ttttcactgg aggcgtcatt 2760
ttcgcgttga gaagatgttc ttatccaaat ttcaactgtt atataga 2807
<210> 4
<211> 1520
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
agtgatcccc cacacaccat agcttcaaaa tgtttctact ccttttttac tcttccagat 60
tttctcggac tccgcgcatc gccgtaccac ttcaaaacac ccaagcacag catactaaat 120
ttcccctctt tcttcctcta gggtgtcgtt aattacccgt actaaaggtt tggaaaagaa 180
aaaagagacc gcctcgtttc tttttcttcg tcgaaaaagg caataaaaat ttttatcacg 240
tttctttttc ttgaaaattt ttttttttga tttttttctc tttcgatgac ctcccattga 300
tatttaagtt aataaacggt cttcaatttc tcaagtttca gtttcatttt tcttgttcta 360
ttacaacttt ttttacttct tgctcattag aaagaaagca tagcaatcta atctaagttt 420
taattacaaa atgtctgcta gaggtttgaa taagatctct tgttctttga atttgcaaac 480
tgaaaaattg tgttacgaag ataacgataa cgatttggat gaagaattga tgccaaagca 540
tatcgctttg atcatggatg gtaacagaag atgggcaaaa gataaaggtt tagaagttta 600
cgaaggtcat aagcatatca tcccaaaatt gaaggaaatt tgtgatattt cttcaaaatt 660
gggtattcaa atcatcactg ctttcgcatt ttctacagaa aactggaaga gatcaaagga 720
agaagttgat ttcttgttac aaatgttcga agaaatctat gatgaatttt ctagatcagg 780
tgttagagtt tctatcatcg gttgtaagtc agatttgcca atgactttgc aaaagtgtat 840
cgctttgaca gaagaaacta caaagggtaa taagggtttg catttggtta ttgcattgaa 900
ctacggtggt tactacgata tcttgcaagc tactaagtca atcgttaata aggcaatgaa 960
cggtttgtta gatgttgaag atatcaataa gaatttgttc gatcaagaat tagaatctaa 1020
gtgtccaaac ccagatttgt tgattagaac tggtggtgaa caaagagttt caaatttctt 1080
gttgtggcaa ttggcttaca cagaattcta cttcactaac acattgttcc cagatttcgg 1140
tgaagaagat ttgaaggaag caatcatgaa cttccaacaa agacatagaa gattcggtgg 1200
tcatacatat taaccgctga tcctagaggg ccgcatcatg taattagtta tgtcacgctt 1260
acattcacgc cctcccccca catccgctct aaccgaaaag gaaggagtta gacaacctga 1320
agtctaggtc cctatttatt tttttatagt tatgttagta ttaagaacgt tatttatatt 1380
tcaaattttt cttttttttc tgtacagacg cgtgtacgca tgtaacatta tactgaaaac 1440
cttgcttgag aaggttttgg gacgctcgaa ggctttaatt tgcaagctgc ggccctgcat 1500
taatgaatcg gccaacgcgc 1520
<210> 5
<211> 1993
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
catcataagg aattccggga ttctccccat gaaaggtatc tggatctacc actgcaccta 60
aaattacatg caagctaaag tgtttatttt gttgggatgg tttcttcacg ctaattgatg 120
aagcaaattg aactctttca taacgggcaa ctttctgaat agaatcttct ggataggaaa 180
acaataaaga gtccactcca tattcttcat aattaacgtg gtctctgtgc aaataaaaag 240
tggaatcgta ttttttcatt ttagtgatat ttcgaacatt tgaagcttct cttatgattt 300
gatgttttgg caaaggggaa ggcaccaacg gacatactga aggacaaaat tgaggacctt 360
tgtcgcgttt cgctgtatgc tggacgagat tgatttccgt gtcgtcgtcg tcattcttag 420
cttttatttt gatagcgaaa tattgcactc ttaatctgct ttctactgaa gagtcttcaa 480
cgagaagatc aaaactgctc tttaaaaaag tatccaaatc acaatttgcc gtttcaaacg 540
ttgatactaa ggtaaaataa tttcttttat aacctaccca ctcttcatca atatggtcga 600
acgtttaaag cggtttaaac gtgtcactac ataagaacac ctttggtgga gggaacatcg 660
ttggtaccat tgggcgaggt ggcttctctt atggcaaccg caagagcctt gaacgcactc 720
tcactacggt gatgatcatt cttgcctcgc agacaatcaa cgtggagggt aattctgcta 780
gcctctgcaa agctttcaag aaaatgcggg atcatctcgc aagagagatc tcctactttc 840
tccctttgca aaccaagttc gacaactgcg tacggcctgt tcgaaagatc taccaccgct 900
ctggaaagtg cctcatccaa aggcgcaaat cctgatccaa acctttttac tccacgcgcc 960
agtagggcct ctttaaaagc ttgaccgaga gcaatcccgc agtcttcagt ggtgtgatgg 1020
tcgtctatgt gtaagtcacc aatgcactca acgattagcg accagccgga atgcttggcc 1080
agagcatgta tcatatggtc cagaaaccct atacctgtgt ggacgttaat cacttgcgat 1140
tgtgtggcct gttctgctac tgcttctgcc tctttttctg ggaagatcga gtgctctatc 1200
gctaggggac caccctttaa agagatcgca atctgaatct tggtttcatt tgtaatacgc 1260
tttactaggg ctttctgctc tgtcatcttt gccttcgttt atcttgcctg ctcatttttt 1320
agtatattct tcgaagaaat cacattactt tatataatgt ataattcatt atgtgataat 1380
gccaatcgct aagaaaaaaa aagagtcatc cgctaggtgg aaaaaaaaaa atgaaaatca 1440
ttaccgaggc ataaaaaaat atagagtgta ctagaggagg ccaagagtaa tagaaaaaga 1500
aaattgcggg aaaggactgt gttatgactt ccctgactaa tgccgtgttc aaacgatacc 1560
tggcagtgac tcctagcgct caccaagctc ttaaaacgga attatggtgc actctcagta 1620
caatctgctc tgatgccgca tagttaagcc agccccgaca cccgccaaca cccgctgacg 1680
cgccctgacg ggcttgtctg ctcccggcat ccgcttacag acaagctgtg accgtctccg 1740
ggagctgcat gtgtcagagg ttttcaccgt catcaccgaa acgcgcgatc cggacgccac 1800
cgctggtacc gagctcggat ccactagtaa cggccgccag tgtgctggaa ttgcccttaa 1860
gggcaattct gcagatatcc atcacactgg cggccgctcg agcatgcatc tagagggccc 1920
aattcgccct atagtgagtc gtattacaat tcactggccg tcgttttaca acgtcgtgac 1980
tgggaaaacc ctg 1993
<210> 6
<211> 1746
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
ccgactggaa agcgggcagt gagcgcaacg caattaatgt gagttagctc actcattagg 60
caccccaggc tttacacttt atgcttccgg ctcgtatgtt gtgtggaatt gtgagcggat 120
aacaatttca cacaggaaac agctatgacc atgattacgc caagctgggc tggcttaact 180
atgcggcatc agagcagatt gtactgagag tgcaccatac caccttttca attcatcatt 240
ttttttttat tctttttttt gatttcggtt tccttgaaat ttttttgatt cggtaatctc 300
cgaacagaag gaagaacgaa ggaaggagca cagacttaga ttggtatata tacgcatatg 360
tagtgttgaa gaaacatgaa attgcccagt attcttaacc caactgcaca gaacaaaaac 420
ctgcaggaaa cgaagataaa tcatgtcgaa agctacatat aaggaacgtg ctgctactca 480
tcctagtcct gttgctgcca agctatttaa tatcatgcac gaaaagcaaa caaacttgtg 540
tgcttcattg gatgttcgta ccaccaagga attactggag ttagttgaag cattaggtcc 600
caaaatttgt ttactaaaaa cacatgtgga tatcttgact gatttttcca tggagggcac 660
agttaagccg ctaaaggcat tatccgccaa gtacaatttt ttactcttcg aagacagaaa 720
atttgctgac attggtaata cagtcaaatt gcagtactct gcgggtgtat acagaatagc 780
agaatgggca gacattacga atgcacacgg tgtggtgggc ccaggtattg ttagcggttt 840
gaagcaggcg gcagaagaag taacaaagga acctagaggc cttttgatgt tagcagaatt 900
gtcatgcaag ggctccctat ctactggaga atatactaag ggtactgttg acattgcgaa 960
gagcgacaaa gattttgtta tcggctttat tgctcaaaga gacatgggtg gaagagatga 1020
aggttacgat tggttgatta tgacacccgg tgtgggttta gatgacaagg gagacgcatt 1080
gggtcaacag tatagaaccg tggatgatgt ggtctctaca ggatctgaca ttattattgt 1140
tggaagagga ctatttgcaa agggaaggga tgctaaggta gagggtgaac gttacagaaa 1200
agcaggctgg gaagcatatt tgagaagatg cggccagcaa aactaagcgg tttaaacatg 1260
actgctgaag aatttgattt ttctagccat tcccatagac gttacaatcc actaaccgat 1320
tcatggatct tagtttctcc acacagagct aaaagacctt ggttaggtca acaggaggct 1380
gcttacaagc ccacagctcc attgtatgat ccaaaatgct atctatgtcc tggtaacaaa 1440
agagctactg gtaacctaaa cccaagatat gaatcaacgt atattttccc caatgattat 1500
gctgccgtta ggctcgatca acctatttta ccacagaatg attccaatga ggataatctt 1560
aaaaataggc tgcttaaagt gcaatctgtg agaggcaatt gtttcgtcat atgttttagc 1620
cccaatcata atctaaccat tccacaaatg aaacaatcag atctggttca tattgttaat 1680
tcttggcaag cattgactga cgatctctcc agagaagcaa gagaaaatca taagcctttc 1740
aaatat 1746
<210> 7
<211> 2405
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
atactagcgt tgaatgttag cgtcaacaac aagaagttta atgacgcgga ggccaaggca 60
aaaagattcc ttgattacgt aagggagtta gaatcatttt gaataaaaaa cacgcttttt 120
cagttcgagt ttatcattat caatactgcc atttcaaaga atacgtaaat aattaatagt 180
agtgattttc ctaactttat ttagtcaaaa aattagcctt ttaattctgc tgtaacccgt 240
acatgcccaa aatagggggc gggttacaca gaatatataa catcgtaggt gtctgggtga 300
acagtttatt cctggcatcc actaaatata atggagcccg ctttttaagc tggcatccag 360
aaaaaaaaag aatcccagca ccaaaatatt gttttcttca ccaaccatca gttcataggt 420
ccattctctt agcgcaacta cagagaacag gggcacaaac aggcaaaaaa cgggcacaac 480
ctcaatggag tgatgcaacc tgcctggagt aaatgatgac acaaggcaat tgacccacgc 540
atgtatctat ctcattttct tacaccttct attaccttct gctctctctg atttggaaaa 600
agctgaaaaa aaaggttgaa accagttccc tgaaattatt cccctacttg actaataagt 660
atataaagac ggtaggtatt gattgtaatt ctgtaaatct atttcttaaa cttcttaaat 720
tctactttta tagttagtct tttttttagt tttaaaacac caagaactta gtttcgaata 780
aacacacata aacaaacaaa atgccatttg ttaaggactt taagccacaa gctttgggtg 840
acaccaactt attcaaacca atcaaaattg gtaacaatga acttctacac cgtgctgtca 900
ttcctccatt gactagaatg agagcccaac atccaggtaa tattccaaac agagactggg 960
ccgttgaata ctacgctcaa cgtgctcaaa gaccaggaac cttgattatc actgaaggta 1020
cctttccctc tccacaatct gggggttacg acaatgctcc aggtatctgg tccgaagaac 1080
aaattaaaga atggaccaag attttcaagg ctattcatga gaataaatcg ttcgcatggg 1140
tccaattatg ggttctaggt tgggctgctt tcccagacac ccttgctagg gatggtttgc 1200
gttacgactc cgcttctgac aacgtgtata tgaatgcaga acaagaagaa aaggctaaga 1260
aggctaacaa cccacaacac agtataacaa aggatgaaat taagcaatac gtcaaagaat 1320
acgtccaagc tgccaaaaac tccattgctg ctggtgccga tggtgttgaa atccacagcg 1380
ctaacggtta cttgttgaac cagttcttgg acccacactc caataacaga accgatgagt 1440
atggtggatc catcgaaaac agagcccgtt tcaccttgga agtggttgat gcagttgtcg 1500
atgctattgg ccctgaaaaa gtcggtttga gattgtctcc atatggtgtc ttcaacagta 1560
tgtctggtgg tgctgaaacc ggtattgttg ctcaatatgc ttatgtctta ggtgaactag 1620
aaagaagagc taaagctggc aagcgtttgg ctttcgtcca tctagttgaa cctcgtgtca 1680
ccaacccatt tttaactgaa ggtgaaggtg aatacaatgg aggtagcaac aaatttgctt 1740
attctatctg gaagggccca attattagag ctggtaactt tgctctgcac ccagaagttg 1800
tcagagaaga ggtgaaggat cctagaacat tgatcggtta cggtagattt tttatctcta 1860
atccagattt ggttgatcgt ttggaaaaag ggttaccatt aaacaaatat gacagagaca 1920
ctttctacaa aatgtcagct gagggataca ttgactaccc tacgtacgaa gaagctctaa 1980
aactcggttg ggacaaaaat taagattaat ataattatat aaaaatatta tcttcttttc 2040
tttatatcta gtgttatgta aaataaattg atgactacgg aaagcttttt tatattgttt 2100
ctttttcatt ctgagccact taaatttcgt gaatgttctt gtaagggacg gtagatttac 2160
aagtgataca acaaaaagca aggcgctttt tctaataaaa agaagaaaag catttaacaa 2220
ttgaacacct ctatatcaac gaagaatatt actttgtctc taaatccttg taaaatgtgt 2280
acgatctcta tatgggttac tcataagtgt accgaagact gcattgaaag tttatgtttt 2340
ttcactggag gcgtcatttt cgcgttgaga agatgttctt atccaaattt caactgttat 2400
ataga 2405
<210> 8
<211> 3413
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 8
agtgatcccc cacacaccat agcttcaaaa tgtttctact ccttttttac tcttccagat 60
tttctcggac tccgcgcatc gccgtaccac ttcaaaacac ccaagcacag catactaaat 120
ttcccctctt tcttcctcta gggtgtcgtt aattacccgt actaaaggtt tggaaaagaa 180
aaaagagacc gcctcgtttc tttttcttcg tcgaaaaagg caataaaaat ttttatcacg 240
tttctttttc ttgaaaattt ttttttttga tttttttctc tttcgatgac ctcccattga 300
tatttaagtt aataaacggt cttcaatttc tcaagtttca gtttcatttt tcttgttcta 360
ttacaacttt ttttacttct tgctcattag aaagaaagca tagcaatcta atctaagttt 420
taattacaaa atgtctgctt gtactccttt ggcatctgct atgccattgt cttctactcc 480
attgattaac ggtgataatt ctcagagaaa aaatacaaga caacatatgg aagagtcttc 540
atctaaaaga agagaatatt tgttggaaga aacaacaaga aaattgcaaa gaaacgatac 600
tgaatctgtt gagaaattaa aattgataga taacattcaa caattaggta ttggatacta 660
ttttgaagat gctataaatg ctgttttacg ttctcctttt tctacaggtg aagaagattt 720
gtttacagct gcattgagat ttaggttgtt gaggcataat ggtattgaaa tttctcctga 780
aattttcttg aagttcaaag atgaaagggg aaagttcgat gaatctgata ctttgggttt 840
attgtcttta tacgaggctt caaacttggg tgttgctggt gaagagattt tggaggaggc 900
tatggagttc gctgaagcta ggttgaggag gtctttgtct gagccagcag ctccattgca 960
cggtgaagtt gcacaggctt tagacgtccc aaggcacttg agaatggcta gattggaagc 1020
tagaagattt attgaacaat acggtaagca gtctgaccat gacggtgact tgttggaatt 1080
ggcaatttta gattataacc aagtccaggc tcagcaccag tctgaattga cagaaattat 1140
taggtggtgg aaagaattgg gattggttga taaattatct tttggtagag atagaccatt 1200
ggaatgcttt ttgtggactg tcggtttgtt gccagagcca aagtattctt ctgttagaat 1260
tgagttggct aaagctattt ctattttgtt ggttattgat gatattttcg atacatacgg 1320
tgaaatggat gatttaattt tgttcactga cgctattaga aggtgggact tagaggctat 1380
ggaaggttta cctgaatata tgaagatttg ctacatggct ttgtacaata ctacaaacga 1440
agtttgttat aaagttttaa gagatactgg tagaattgtt ttgttaaatt tgaaatcaac 1500
ttggattgat atgattgaag gttttatgga agaggctaaa tggttcaacg gaggttctgc 1560
tcctaagttg gaggaatata ttgaaaatgg tgtttcaact gctggtgctt acatggcttt 1620
cgctcatatt ttctttttaa ttggagaagg tgttactcat caaaattctc aattgttcac 1680
tcaaaagcca tatccaaaag tcttttctgc tgcaggtaga attttgagat tgtgggacga 1740
cttgggtaca gctaaggagg agcaagagag gggtgattta gcttcttgtg ttcaattatt 1800
tatgaaggaa aaatcattga ctgaagagga ggctagatct agaattttgg aagaaattaa 1860
gggtttatgg agagatttga atggtgagtt ggtctataat aagaatttac cattatcaat 1920
tattaaagtc gctttgaaca tggctagggc ttctcaggtc gtctataaac acgatcaaga 1980
tacttacttt tcttctgttg acaattacgt tgatgcttta tttttcactc aataaggtgg 2040
tggttctatg gcttcagaaa aagaaattag gagagagaga ttcttgaacg ttttccctaa 2100
attagtagag gaattgaacg catcgctttt ggcttacggt atgcctaagg aagcatgtga 2160
ctggtatgcc cactcattga actacaacac tccaggcggt aagctaaata gaggtttgtc 2220
cgttgtggac acgtatgcta ttctctccaa caagaccgtt gaacaattgg ggcaagaaga 2280
atacgaaaag gttgccattc taggttggtg cattgagttg ttgcaggctt actggttggt 2340
cgccgatgat atgatggaca agtccattac cagaagaggc caaccatgtt ggtacaaggt 2400
tcctgaagtt ggggaaattg ccatctggga cgcattcatg ttagaggctg ctatctacaa 2460
gcttttgaaa tctcacttca gaaacgaaaa atactacata gatatcaccg aattgttcca 2520
tgaggtcacc ttccaaaccg aattgggcca attgatggac ttaatcactg cacctgaaga 2580
caaagtcgac ttgagtaagt tctccctaaa gaagcactcc ttcatagtta ctttcaagac 2640
tgcttactat tctttctact tgcctgtcgc attggccatg tacgttgccg gtatcacgga 2700
tgaaaaggat ttgaaacaag ccagagatgt cttgattcca ttgggtgaat acttccaaat 2760
tcaagatgac tacttagact gcttcggtac cccagaacag atcggtaaga tcggtacaga 2820
tatccaagat aacaaatgtt cttgggtaat caacaaggca ttggaacttg cttccgcaga 2880
acaaagaaag actttagacg aaaattacgg taagaaggac tcagtcgcag aagccaaatg 2940
caaaaagatt ttcaatgact tgaaaattga acagctatac cacgaatatg aagagtctat 3000
tgccaaggat ttgaaggcca aaatttctca ggtcgatgag tctcgtggct tcaaagctga 3060
tgtcttaact gcgttcttga acaaagttta caagagaagc aaatagccgc tgatcctaga 3120
gggccgcatc atgtaattag ttatgtcacg cttacattca cgccctcccc ccacatccgc 3180
tctaaccgaa aaggaaggag ttagacaacc tgaagtctag gtccctattt atttttttat 3240
agttatgtta gtattaagaa cgttatttat atttcaaatt tttctttttt ttctgtacag 3300
acgcgtgtac gcatgtaaca ttatactgaa aaccttgctt gagaaggttt tgggacgctc 3360
gaaggcttta atttgcaagc tgcggccctg cattaatgaa tcggccaacg cgc 3413
<210> 9
<211> 911
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 9
gtccaaatat ttgaaaacaa aggtacagcc atgggttgtt ccaacttaca tccacatggc 60
caagcttggt gcttagaatc catccctagt gaagtttcgc aagaattgaa atcttttgat 120
aaatataaac gtgaacacaa tactgatttg tttgccgatt acgtcaaatt agaatcaaga 180
gagaagtcaa gagtcgtagt ggagaatgaa tcctttattg ttgttgttcc atactgggcc 240
atctggccat ttgagacctt ggtcatttca aagaagaagc ttgcctcaat tagccaattt 300
aaccaaatgg tgaaggagga cctcgcctcg attttaaagc aactaactat taagtatgat 360
aatttatttg aaacgagttt cccatactca atgggtatcc atcaggctcc tttgaatgcg 420
actggtgatg aattgagtaa tagttggttt cacatgcatt tctacccacc tttactgaga 480
tcagctactg ttcggaaatt cttggttggt tttgaattgt taggtgagcc tcaaagagat 540
ttaacttcgg aacaagctgc tgaaaaacta agaaatttag atggtcagat tcattatcta 600
caaagactgt aatggtaccg agctcggatc cactagtaac ggccgccagt gtgctggaat 660
tgcccttaag ggcaattctg cagatatcca tcacactggc ggccgctcga gcatgcatct 720
agagggccca attcgcccta tagtgagtcg tattacaatt cactggccgt cgttttacaa 780
cgtcgtgact gggaaaaccc tggcgttacc caacttaatc gccttgcagc acatccccct 840
ttcgccagct ggcgtaatag cgaagaggcc cgcaccgatc gcccttccca acagttgcgc 900
agcctgaatg g 911
<210> 10
<211> 352
<212> PRT
<213> Artificial sequence (Artificial Sequence)
<400> 10
Met Ala Ser Glu Lys Glu Ile Arg Arg Glu Arg Phe Leu Asn Val Phe
1 5 10 15
Pro Lys Leu Val Glu Glu Leu Asn Ala Ser Leu Leu Ala Tyr Gly Met
20 25 30
Pro Lys Glu Ala Cys Asp Trp Tyr Ala His Ser Leu Asn Tyr Asn Thr
35 40 45
Pro Gly Gly Lys Leu Asn Arg Gly Leu Ser Val Val Asp Thr Tyr Ala
50 55 60
Ile Leu Ser Asn Lys Thr Val Glu Gln Leu Gly Gln Glu Glu Tyr Glu
65 70 75 80
Lys Val Ala Ile Leu Gly Trp Cys Ile Glu Leu Leu Gln Ala Tyr Trp
85 90 95
Leu Val Ala Asp Asp Met Met Asp Lys Ser Ile Thr Arg Arg Gly Gln
100 105 110
Pro Cys Trp Tyr Lys Val Pro Glu Val Gly Glu Ile Ala Ile Trp Asp
115 120 125
Ala Phe Met Leu Glu Ala Ala Ile Tyr Lys Leu Leu Lys Ser His Phe
130 135 140
Arg Asn Glu Lys Tyr Tyr Ile Asp Ile Thr Glu Leu Phe His Glu Val
145 150 155 160
Thr Phe Gln Thr Glu Leu Gly Gln Leu Met Asp Leu Ile Thr Ala Pro
165 170 175
Glu Asp Lys Val Asp Leu Ser Lys Phe Ser Leu Lys Lys His Ser Phe
180 185 190
Ile Val Thr Phe Lys Thr Ala Tyr Tyr Ser Phe Tyr Leu Pro Val Ala
195 200 205
Leu Ala Met Tyr Val Ala Gly Ile Thr Asp Glu Lys Asp Leu Lys Gln
210 215 220
Ala Arg Asp Val Leu Ile Pro Leu Gly Glu Tyr Phe Gln Ile Gln Asp
225 230 235 240
Asp Tyr Leu Asp Cys Phe Gly Thr Pro Glu Gln Ile Gly Lys Ile Gly
245 250 255
Thr Asp Ile Gln Asp Asn Lys Cys Ser Trp Val Ile Asn Lys Ala Leu
260 265 270
Glu Leu Ala Ser Ala Glu Gln Arg Lys Thr Leu Asp Glu Asn Tyr Gly
275 280 285
Lys Lys Asp Ser Val Ala Glu Ala Lys Cys Lys Lys Ile Phe Asn Asp
290 295 300
Leu Lys Ile Glu Gln Leu Tyr His Glu Tyr Glu Glu Ser Ile Ala Lys
305 310 315 320
Asp Leu Lys Ala Lys Ile Ser Gln Val Asp Glu Ser Arg Gly Phe Lys
325 330 335
Ala Asp Val Leu Thr Ala Phe Leu Asn Lys Val Tyr Lys Arg Ser Lys
340 345 350
Claims (8)
1. A construction method of recombinant saccharomyces cerevisiae is characterized in that: comprising the following steps: and (3) modifying the original saccharomyces cerevisiae 1), 2) or 3) to obtain the recombinant saccharomyces cerevisiae:
the 1) modifications are the following A3, A5 and A6 modifications;
said 2) being adapted to further perform A1, A2, A3 and A4 modifications on the recombinant Saccharomyces cerevisiae obtained by said 1) modification;
said 3) engineering to further perform A1 and A2 engineering on the recombinant Saccharomyces cerevisiae obtained by said 2) engineering;
a1, introducing a geraniol synthase gene ObGES gene;
a2, introduction of the double point mutant Gene ERG20 at positions 96 and 127 of the farnesyl pyrophosphate synthetase Gene F96W/N127W Genes of ERG20 F96W/N127W Gene encoded ERG20 F96W/N127W The sequence of the protein is shown as SEQ ID No. 10;
a3, introducing A3-hydroxy-3-methylglutaryl-CoA reductase gene tHMG1 gene;
a4, introducing a geraniol reductase gene OYE 2;
a5, introducing a nerol synthase GmNES gene;
a6, introducing a neryl diphosphate synthase SINPS 1 gene;
the Saccharomyces cerevisiae is also modified as follows B1-B8:
b1, replacing a promoter of an ERG20 gene of a driving farnesyl pyrophosphate synthetase gene with a promoter of an ERG7 gene named pERG 7;
b2, introducing a mevalonate kinase gene ERG 12;
b3, introducing an isopentenyl pyrophosphate isomerase gene IDI 1;
b4, introducing an MVAPP decarboxylase gene ERG 19;
b5, introducing HMG-CoA reductase gene HMGR gene;
b6, introducing a 3-hydroxy-3-methylglutaryl-CoA synthase gene ERG 13;
b7, introducing an MVAP kinase gene ERG8 gene;
b8, introducing an acetyl-CoA acetyltransferase gene ERG 10.
2. The method according to claim 1, characterized in that:
the sequence of the ObGES protein encoded by the ObGES gene is genbank login number: AMK97466.1 sequence 35-569;
and/or, the sequence of the tHMG1 protein coded by the tHMG1 gene is genbank login number: AJS96703.1 sequence is shown at positions 530-1054;
and/or, the sequence of the OYE2 protein encoded by the OYE2 gene is genbank login number: the sequence NP 012049.1 is shown;
and/or, the sequence of the GmNES protein encoded by the GmNES gene is genbank login number: AEE92791.1 sequence;
and/or, the SINPS 1 protein coded by the SINPS 1 gene has the sequence of genbank login number: the QNM36897.1 sequence is shown.
3. The method according to claim 1 or 2, characterized in that:
the sequence of the ObGES gene is shown in the 431 th to 2035 th positions of SEQ ID NO. 8;
and/or, the ERG20 F96W/N127W The sequence of the gene is shown in 2048 th to 3106 th positions in SEQ ID NO. 8;
and/or the sequence of the tHMG1 gene is shown in 757 th to 2340 th positions in SEQ ID NO. 2;
and/or the sequence of the OYE2 gene is shown in the 801 st position to the 2003 st position in SEQ ID NO. 7;
and/or the sequence of the GmNES gene is shown in the 801 st position to 2405 th position in SEQ ID NO. 3;
and/or the sequence of the SINPS 1 gene is shown in the 431 th to 1213 rd positions of SEQ ID NO. 4.
4. The method according to claim 1 or 2, characterized in that:
the A1 and A2 are obtained by introducing an ObGES gene and ERG20 into the Saccharomyces cerevisiae F96W/N127W Realizing a gene expression cassette;
and/or, said A3 is achieved by introducing a hmg1 gene expression cassette into said s.cerevisiae;
and/or, the A4 is realized by introducing an OYE2 gene expression cassette into the saccharomyces cerevisiae;
and/or, the A5 is realized by introducing a GmNES gene expression cassette into the saccharomyces cerevisiae;
and/or, said A6 is achieved by introducing a SINDPS1 gene expression cassette into said s.cerevisiae;
and/or, said B2 is achieved by introducing an ERG12 gene expression cassette into said s.cerevisiae;
and/or, said B3 is achieved by introducing an IDI1 gene expression cassette into said s.cerevisiae;
and/or, said B4 is achieved by introducing an ERG19 gene expression cassette into said s.cerevisiae;
and/or, said B5 is achieved by introducing an HMGR gene expression cassette into said s.cerevisiae;
and/or, said B6 is achieved by introducing an ERG13 gene expression cassette into said s.cerevisiae;
and/or, said B7 is achieved by introducing an ERG8 gene expression cassette into said s.cerevisiae;
and/or, the B8 is realized by introducing an ERG10 gene expression cassette into the saccharomyces cerevisiae.
5. The method according to claim 1 or 2, characterized in that: in the recombinant Saccharomyces cerevisiae, the ObGES gene and ERG20 F96W/N127W The gene is expressed by introducing an expression plasmid in the saccharomyces cerevisiae; tHMG1 gene, obGES gene and ERG20 F96W/N127W The gene is integrated into the Gal70 locus of the Saccharomyces cerevisiae; the tHMG1 gene, the GmNES gene and the SINTS 1 gene are integrated into the NDT80 locus of the Saccharomyces cerevisiae; the pERG7 replaces positions 1-248 of the promoter driving the ERG20 gene.
6. Recombinant s.cerevisiae constructed by the method of any one of claims 1-5.
7. A process for producing a terpene, characterized by either:
(1) Culturing the recombinant s.cerevisiae obtained by the modification of 1) in the method of any one of claims 1 to 5 to obtain a fermentation product; obtaining nerol from the fermentation product;
(2) Culturing the recombinant s.cerevisiae obtained by the modification of 2) in the method of any one of claims 1 to 5 to obtain a fermentation product; obtaining geraniol, citronellol, and/or nerol from the fermentation product;
(3) Culturing the recombinant s.cerevisiae obtained by the modification of 3) in the method of any one of claims 1 to 5 to obtain a fermentation product; geraniol, citronellol, and/or nerol are obtained from the fermentation product.
8. In any of the applications described in the following,
use of X1a, the method of any one of claims 1-5 for the production of nerol when 1) retrofitting is performed;
use of X1b, the method of any one of claims 1-5 for the production of geraniol, citronellol and/or nerol when 2) retrofitting is performed;
use of X1c, the method of any one of claims 1-5 for the production of geraniol, citronellol and/or nerol when carrying out the modification of 3);
use of the recombinant saccharomyces cerevisiae obtained by 1) modification of X2a, the method according to any one of claims 1-5, for the production of nerol;
use of the recombinant saccharomyces cerevisiae obtained by 2) modification of the method according to any of the claims 1-5 for the production of geraniol, citronellol and/or nerol;
use of the recombinant saccharomyces cerevisiae obtained by 3) modification of the method according to any of the claims 1-5 for the production of geraniol, citronellol and/or nerol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110508671.9A CN115322913B (en) | 2021-05-10 | 2021-05-10 | Recombinant saccharomyces cerevisiae for producing rose essential oil, and construction method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110508671.9A CN115322913B (en) | 2021-05-10 | 2021-05-10 | Recombinant saccharomyces cerevisiae for producing rose essential oil, and construction method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115322913A CN115322913A (en) | 2022-11-11 |
CN115322913B true CN115322913B (en) | 2024-03-22 |
Family
ID=83913050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110508671.9A Active CN115322913B (en) | 2021-05-10 | 2021-05-10 | Recombinant saccharomyces cerevisiae for producing rose essential oil, and construction method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115322913B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102925376A (en) * | 2012-11-13 | 2013-02-13 | 天津工业生物技术研究所 | Recombinant microorganism for preparing dharma diene and protopanoxadiol and construction method thereof |
CN103820344A (en) * | 2011-12-30 | 2014-05-28 | 天津工业生物技术研究所 | Brewer yeast gene engineering strains for producing miltiradiene, and construction method and application of brewer yeast gene engineering strains |
WO2018082588A1 (en) * | 2016-11-04 | 2018-05-11 | 中国科学院天津工业生物技术研究所 | Recombinant yeast and use thereof |
-
2021
- 2021-05-10 CN CN202110508671.9A patent/CN115322913B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103820344A (en) * | 2011-12-30 | 2014-05-28 | 天津工业生物技术研究所 | Brewer yeast gene engineering strains for producing miltiradiene, and construction method and application of brewer yeast gene engineering strains |
CN102925376A (en) * | 2012-11-13 | 2013-02-13 | 天津工业生物技术研究所 | Recombinant microorganism for preparing dharma diene and protopanoxadiol and construction method thereof |
WO2018082588A1 (en) * | 2016-11-04 | 2018-05-11 | 中国科学院天津工业生物技术研究所 | Recombinant yeast and use thereof |
CN108060092A (en) * | 2016-11-04 | 2018-05-22 | 中国科学院天津工业生物技术研究所 | A kind of recombinant bacterium and application thereof |
Non-Patent Citations (2)
Title |
---|
Production of plant volatile terpenoids (rose oil) by yeast cell factories;Rongsheng Li et al.;《Green Chem.》;第23卷;第5088-5096页 * |
高产橙花叔醇的酵母细胞工厂创建;张丽丽等;《中国中药杂志》;第42卷(第15期);第2962-2968页 * |
Also Published As
Publication number | Publication date |
---|---|
CN115322913A (en) | 2022-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111434773B (en) | Recombinant yeast for high-yield sandalwood oil and construction method and application thereof | |
US20240010969A1 (en) | Recombinant yeast and use thereof | |
CN110982721B (en) | Method for improving yield of saccharomyces cerevisiae metabolites | |
WO2023208037A1 (en) | Nerolidol synthase and use thereof | |
CN114058525A (en) | High-yield squalene genetic engineering bacterium and construction method and application thereof | |
CN115305254B (en) | Terpenoid chassis microorganism and engineering bacterium as well as construction method and application thereof | |
CN110804561B (en) | Saccharomyces cerevisiae with high yield of C6-C10 ethyl ester and construction method and application thereof | |
CN112608936B (en) | Promoter for regulating and controlling expression of exogenous gene of yeast, regulating and controlling method and application thereof | |
CN109913380A (en) | Recombinant yarrowia lipolytica for producing (-) - α -bisabolol and construction method and application thereof | |
CN115322913B (en) | Recombinant saccharomyces cerevisiae for producing rose essential oil, and construction method and application thereof | |
Zhang et al. | Phenotypes and fed-batch fermentation of ubiquinone-overproducing fission yeast using ppt1 gene | |
CN117187225A (en) | Nerolidol synthetase and application | |
CN114525215B (en) | Recombinant strain for producing terpenoid, construction method thereof, method for producing terpenoid through fermentation and application of recombinant strain | |
CN111154665A (en) | Recombinant yarrowia lipolytica and construction method and application thereof | |
WO2012177499A1 (en) | Systems for induction of gene expression and protein depletion in yeast | |
CN116240233A (en) | Method for improving triterpene content of ganoderma lucidum | |
CN114410492A (en) | Engineering bacterium for biosynthesis of cucurbitadienol by taking glucose as substrate, construction and application thereof | |
CN114606146B (en) | Yeast for producing D-limonene and application thereof | |
CN117660474B (en) | Application of pear transcription factor PbrMYB and PbrACO2 gene promoter interaction in regulation of fruit citric acid isomerization | |
CN112920959B (en) | Method for increasing yield of L-menthol in saccharomycetes | |
CN114456964B (en) | Recombinant yarrowia lipolytica for high yield of stigmasterol, construction method thereof, fermentation medium for producing stigmasterol and application | |
KR102185428B1 (en) | Expression vectors for optimal expression of mutated Upc2p and method for overproducing sterol precursors using the same | |
WO2016106988A1 (en) | Recombinant eukaryotic strain for producing taxadiene and method for preparing taxadiene using same | |
CN117925588A (en) | Nerolidol synthetase and application | |
CN118497181A (en) | Gemmarene A synthetase and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |